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Wetenschappelijk onderzoek doen, het is iets speciaals: het ene experiment
levert meer vragen op dan antwoorden, het andere experiment geeft helemaal
geen antwoorden en de nieuwe vragen leiden je alsmaar verder weg. En dit
gedurende vier jaar als onderdeel van een doctoraat. Hoe speel je dit klaar?
Wel, u neemt een beetje boekenworm, een snuifje chirurg, een stukje techneut,
een beetje verkoper en een schijfje wereldburger. Goed mengen en klaar! Veel
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in haar labo te starten. Bedankt Lut voor je onvermoeibaar enthousiasme,
het continu aanbrengen van nieuwe ideëen en je onfeilbare passie om ervoor
te gaan. Sinds jouw intrigerende lessen over neurowetenschap tijdens mijn
opleiding Biologie wist ik het: ik wou en zou onderzoek doen op hersenen en
de keuze voor jouw labo was dan ook snel gemaakt. De veldslag naar het IWT
toe, de spontane discussies in de gang, de MMP meetings en samen op congres:
op elk moment inspireerde je me om nog net dat beetje extra te doen en je
enthousiasme blijft nog steeds besmettelijk! Hierbij wil ik ook mijn co-promotor
bedanken Prof. dr. Lieve Moons: bedankt voor alle input, in het bijzonder
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tijdens de IWT voorbereidingen en bedankt om al mijn output grondig na te
lezen.
Graag wil ik ook mijn juryleden Prof. dr. R. Huybrechts, Prof dr. P. Van Dijck,
dr. T.T. Hu, Prof. dr. C. Libert en Prof. dr. T. Pizzorusso bedanken voor het
nalezen van deze thesis, voor de nuttige suggesties en kritische opmerkingen.
Door jullie is dit werk mede geworden tot wat het nu is, waarvoor mijn oprechte
dank. Thank you Prof. dr. T. Pizzorusso for all your suggestions and valuable
insights and the e ort to travel to Belgium for this occasion. Ook wil ik
graag Prof. dr. G. Opdenakker en Erik Martens bedanken voor de zymografie
pilootstudie.
Een goede sfeer op het labo is goud waard en daarom wil ik alle collega’s
en ex-collega’s bedanken. Bedankt Laurens, Tjing, Annelies, Leen, Katrien,
Samme, Ellen, Isabelle en Marie-Eve. Extra dank gaat naar Tjing: jouw eeuwig
positivisme heeft me door de moeilijkste periodes van mijn doctoraat geholpen.
Ook onze vele discussies en jouw input waren voor mij enorm waardevol, bedankt!
Natuurlijk ook dank aan Laurens: je hebt me alle "goede manieren" in het
labo aangeleerd tijdens mijn thesisjaar en daarna stond je altijd garant voor
knotsgekke avonden uit in Leuven. Katrien, Samme en Jeroen S: bedankt om
samen aan de start als een team te werken naar het IWT toe, de sfeer toen zal
ik nooit vergeten. Ook bedankt aan Ellen, Katrien en Samme voor de gezellige
muzikale avonden. Een speciaal woord van dank gaat ook naar de onnoemlijk
waardevolle en enthousiaste laboranten Ria en Lieve! Bedankt allebei voor jullie
inzet, jullie gouden handen en de leuke babbels. Zonder jullie hulp had ik het
zeker niet gehaald! Eline, bedankt voor de goede samenwerking! Dank ook aan
al mijn thesisstudenten: Jessie, Lise en Sander, jullie waren top.
I also would like to thank Prof. dr. Christian Casanova and Prof. dr. Denis
Boire to give me the opportunity to work in the lab in Montréal. Many thanks
go to a bunch of great people that I was lucky to call colleagues for three months:
Bruno and Jimmy, my dear Caballeros, our time together was much too short
but I will see you on the battlefield! Sebastien aka "Clark Kent", thank you
for one of the best work experiences I ever had. You are truly a Superman in
disguise. Mathieu, aka "The Agarose Master", thanks for the great teamwork on
the rabbit and the nice time in and outside the lab! Thank you Azadeh, Robyn,
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"How can a three-pound mass of jelly that you can hold in
your palm imagine angels, contemplate the meaning of
infinity, and even question its own place in the cosmos?
Especially awe inspiring is the fact that any single brain,
including yours, is made up of atoms that were forged in
the hearts of countless, far-flung stars billions of years
ago. These particles drifted for eons and light-years until
gravity and change brought them together here, now.
These atoms now form a conglomerate - your brain - that
can not only ponder the very stars that gave it birth but
can also think about its own ability to think and wonder
about its own ability to wonder. With the arrival of
humans, it has been said, the universe has suddenly
become conscious of itself. This, truly, it the greatest
mystery of all."
V. S. Ramachandran (from The Tell-Tale Brain: A
Neuroscientist’s Quest for What Makes Us Human, 2011)
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Aim of the study
The mammalian brain is inherently plastic, meaning that it is capable of altering
its structure and function in correspondence to changes in the environment. The
visual cortex, the area in the brain that receives visual input, is undoubtedly
one of the best and most studied areas of the brain for understanding cortical
plasticity and development [96]. On top of unimodal plasticity also cross-modal
changes can occur when input of one sensory modality is lost, for example in the
case of blindness or deafness. Subsequently the deprived cortical neurons get
recruited by the remaining modalities by functional and structural reorganization
and in turn, the function of the remaining modalities strengthens to compensate
for the sensory loss [17]. This type of plasticity has been extensively reported in
several species after both partial deprivation or complete loss of sensory input
[250, 17, 134, 283].
Recent work in our lab uncovered an age-dependent reactivation in the mouse
visual cortex following irreversible sensory loss by removal of one eye, termed
monocular enucleation (ME) [256, 334]. This extensive reactivation was only
present in adults (P120) and consisted of an initial open-eye potentiation followed
by cross-modally driven plasticity in the medial and lateral monocular zones
starting from adjacent non-visual cortices around three weeks post-ME [334]. In
contrast, adolescent (P45) mice did not display cross-modal reactivation at seven
weeks post-ME [256]. The precise cellular mechanisms and key molecular players
underlying these age-dependent processes still remain largely elusive. In that
regard, matrix metalloproteinases (MMPs), Zn2+-dependent endopeptidases
that modulate extracellular matrix proteins, chemokines, cytokines, growth
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factors, receptors and a range of intracellular substrates, have over the years been
identified as major regulators of normal brain development and neuroplasticity
[377, 97, 40, 205]. Interestingly, a recent study by Spolidoro et al. (2012)
uncovered a role for MMPs in critical period plasticity of the visual cortex
in monocular deprived rats. Infusion of a broad-spectrum MMP inhibitor
prevented both the potentiation of the open-eye response and the increase
in spine density on layer II-III pyramidal neurons after MD [309]. However,
further studies concerning the role of MMPs in mediating the structure and
function of the visual cortex, including uni- and cross-modal plasticity, are
lacking. Moreover, the majority of MMP studies have focused on the gelatinases
(MMP-2 and MMP-9) whereas MMP-3 is known to act upstream of MMP-9
[97, 338]. Therefore, the primary interest of this dissertation is to acquire
knowledge specifically about the function of MMP-3 in the mouse visual cortex.
The objective of this study is two-fold: the first aim is to gain insight into the
mechanistic properties of the MMP protease web by characterizing the structural
and functional phenotype of the visual cortex of adult MMP-3 deficient (MMP-
3-/-) mice. The second aim is to establish a role for MMP-3 in age-dependent
ME-induced cortical plasticity. Addressing both aims will lead to a better
understanding of the MMP-3 biology in context of the structure and function
of the visual cortex.
Chapter 1 provides an introduction and overview of the the general principles
governing brain plasticity and MMP biology. In this dissertation we used the
mouse visual system as a research model and therefore the visual pathways
from the retina to the cortex are explained. Special emphasis is laid upon the
structural and functional organization of the visual cortex, both primary and
extrastriate areas. Di erent kinds of plasticity and regulators of plasticity in
the visual cortex are discussed with a focus on ME-induced cortical plasticity
which is one major research pillar in this dissertation. The last part of this
chapter introduces the reader to the world of MMP biology with an overview
of the structure, classification and regulatory mechanisms of MMPs. Finally,
the role of MMPs in structural and functional plasticity and their potential as
therapeutic targets is discussed.
The first research goal of this dissertation was to phenotypically characterize
3the visual cortex of adult MMP-3-/- mice in order to gain insight into the
MMP-3 protease web to guide further studies in visual cortex plasticity research.
Therefore, as described in chapter 2, we performed a Golgi-Cox staining to
compare the neuronal architecture of layer V pyramidal neurons in MMP-3-/-
and WT mice. To corroborate these findings on a molecular level, we assessed
the levels of neurofilament proteins in these mice. Apart from the structural
phenotype we wanted to evaluate the potential for cross-modal plasticity of
adult MMP-3-/- mice by assessing the ME-induced cortical activity profile with
in situ hybridization for the neuronal activity marker zif268.
Chapter 3 further explores the molecular and cellular phenotype of the MMP-
3-/- visual cortex to corroborate the findings of chapter 2. To evaluate the
molecular processes underlying the cortical phenotype a proteomics approach
revealed a set of di erentially expressed proteins between MMP-3-/- and WT
samples. A special interest was given to the family of collapsin response mediator
proteins. In addition we explored cellular processes such as mitochondrial
dynamics and autophagy to probe for a new avenue in MMP-related research.
The second aim of our research was to investigate the acute role of MMP-3 in age-
dependent ME-induced cortical plasticity. In chapter 4 we therefore evaluated
the expression of MMP-3 in the visual cortex of P45 and P120 C57Bl/6J mice
with di erent post-ME survival times to unmask a potential age-dependent
regulating role of these enzymes in both cross-modal plasticity and open-eye
potentiation. We expanded this line of research with MMP-2 and MMP-9, of
which the function in neuroplasticity is well characterized. Condition-specific
changes in MMP expression were evaluated with a combination of Western
analysis and gelatin zymography. In addition, we describe the e orts made to
optimize a fluorescent assay to measure the activity of MMP-3 in mouse brain
samples.
The final chapter, chapter 5, is dedicated to discussing the obtained results in
relation to the current state of knowledge in MMP biology and cortical plasticity.
A theoretical molecular framework is proposed to explain the most prominent
aspects of the MMP-3-/- cortical phenotype described in chapters 2 and 3. The
second part of chapter 5 deals with the findings described in chapter 4 and
discusses new avenues to overcome the problems faced when trying to measure
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the activity of individual MMPs in vivo. Finally, several important remarks
are made in light of future experiments to unravel a causal link between MMP
activity and ME-induced cortical plasticity.
Chapter 1
General introduction
1.1 Neuroplasticity: a dynamic interplay between
the world and the brain
The brain is able to change its functional and anatomical organization in
response to environmental changes and this ability is termed neuroplasticity.
This feature allows a person to, for example learn the fine motor skills necessary
for playing a musical instrument or to combine di erent experimental findings
to synthesize a thesis, which a person is able to read because they trained their
brain to make sense of words. Acquiring and constantly improving these skills is
dependent on adaptations in the organization and function of neural networks
and this is why neuroplasticity is so fundamentally present in every aspect
of our life. The term neuroplasticity was first coined in 1948 by the Polish
neuroscientist Jerzy Konorski but it was not until the groundbreaking work
of Hubel and Wiesel in 1962 that neuroplasticity research laid the foundation
of our current understanding of the development and plasticity of the brain
[362, 148, 149, 96]. The Nobel Prize laureates David Hubel and Torsten Wiesel
started investigating the properties of the visual system of the cat with a main
focus on the visual cortex [148]. In 1963, they described that occluding one eye
during a brief period in early-life produced long-lasting changes in the functional
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properties of the visual cortex and this gave birth to a model system to study
cortical plasticity [362]. For this reason, the visual cortex is undoubtedly one of
the best and most studied areas of the brain for understanding cortical plasticity
and development [96].
1.2 The visual system of the mouse
For the large part of the 20th century, the visual system of the mouse was
neglected in neuroscientific research compared to that of the cat or non-human
primates like the macaque. This was mainly due to the fact that mice are
nocturnal animals and are believed to rely more on tactile and olfactory
information. In accordance, the visual acuity1 of mice (0.5 cycles per degree
(cpd)) is much lower than that of cats (6 cpd) or macaques (46 cpd) [282, 337].
However, in the last decades the mouse proved to be an invaluable model
organism in the field of visual neuroscience, mainly because of transgenic and
knockout technology which enables researchers to study the involvement of a
specific gene product in the development, function and plasticity of the visual
system. The commercial availability of a huge number of transgenic mouse
lines and the establishment of several mouse consortiums and online databases
contribute to the overall increase in use of mice in neuroscientific research [151].
In addition, the small size of their nervous system has the advantage to gather
data simultaneously over a large spatial scale and the absence of gyri make
stereotactic manipulations and in vivo imaging easier. Important to note is
that mice are also safer, simpler and less expensive to maintain compared with
cats or primates.
1.2.1 Perception: from retina to cortex
The first step to visual perception is light emitted or reflected by objects in
the environment that hits the photoreceptors of the retina located in the back
1Visual acuity or the spatial resolving capacity of the visual system determines the
sharpness of vision and is often measured as the maximum distinguishable cycles of a given
stimulus per degree of visual angle (cycles per degree) [41].
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of the eye. Di erent photoreceptors, termed cones and rods, transform the
electromagnetic waves into electrical signals that are transmitted to the retinal
ganglion cells (RGCs) which serve as the sole output neurons of the retina. RGC
axons leave the eye and form the optic nerve. Axons in the optic nerve coming
from the nasal retina cross over at the optic chiasm and target the contralateral
part of the dorsolateral geniculate nucleus (dLGN), the primary relay station
of visual information located in the thalamus [150, 18]. As a consequence,
information from the left visual hemifield is projected to the right side of the
brain and vice versa, with a central overlap of the two hemifields perceived by
both eyes which is termed the binocular visual field. The binocular visual field
of the mouse is very small compared to cats and primates and only comprises
1/3rd of the entire visual field due to the lateral positioning of the eyes [150].
The binocular part of the visual field is perceived by the temporal part of the
retina and the corresponding RGCs project to the ipislateral dLGN. The dLGN
relays information from both eyes to the primary visual cortex (V1) terminating
in a monocular zone, which receives information of the contralateral eye, and a
binocular zone receiving information from both eyes (figure 1.1) [150, 151].
A universal and beautiful feature of the visual system across all examined
mammals [337] to date is that one point in visual space can be traced to a
specific corresponding location along the entire visual system terminating in
V1 and this feature is called retinotopy. More specifically, neighboring retinal
ganglion cells project axons to neighboring neurons in the dLGN, which in turn
project to neighboring neurons in V1. This allows the visual system to form
a single map of the visual field in which adjacent neurons in V1 respond to
adjacent locations in visual space [351, 302, 162, 96]. This form of organization
allows the lateral part of the visual field to be represented in the medial visual
cortex and the upper part of the visual field in the posterior visual cortex
[84, 302].
1.2.2 Other retinorecipient brain regions
A recent study unveiled that the mouse retina projects to approximately 46
di erent brain regions, including the dLGN and the primary visual cortex
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Figure 1.1: Dorsolateral schematic view of the mouse visual system.
Information from the ipsilateral (red) and contralateral (blue) retina partially segregate
at the optic chiasm to project to the dorsolateral geniculate nucleus (dLGN) and the
superior colliculus (SC). The dLGN targets the primary visual cortex (V1) which is
composed of a monocular zone (Mz) which only receives input from the contralateral
eye and the binocular zone (Bz) which receives information from both eyes. Adapted
from [363].
which makes up the major image-forming pathway [234]. A subset of RGCs
relays information through non-image-forming pathways and target regions
such as the suprachiasmatic nuclei of the hypothalamus, the ventral LGN and
the intergeniculate leaflet [132]. These retinofugal projections are involved
in circadian rhythm and pupillary reflexes [132, 18, 41]. In mice and other
nocturnal rodent species, nearly all RGCs leaving the optic chiasm also project
to the superior colliculus (SC) (figure 1.1), whereas only a subpopulation targets
the visual cortex via relays in the dLGN (figure 1.1) [41]. This is in sheer
contrast with carnivores and primates in which the majority of RGCs project
to the geniculocortical system and less than 10% targets the SC [18, 41]. The
mouse SC is composed of seven distinct anatomical layers and receives visual
information almost exclusively in the three superficial layers [313]. The deeper
layers are characterized by multisensory neurons that receive input from the
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superficial layers and respond to visual, auditory and somatosensory information
[218, 313]. All this multisensory information is topographically mapped and
integrated [313, 42], and together with cortical input a motor output is generated
that regulates eye, head and body movements towards new stimuli [313, 41].
1.2.3 The primary visual cortex
The visual cortex, a cortical area common to all mammalian species, is
responsible for complex integration and interpretation of information relayed
from the eye to provide a rich visual sensory experience. Like the cortex of
all mammals, the visual cortex of mice consists of six anatomically distinct
layers numbered with Roman numerals (I to VI). Accross these layers, two
neuron types are present: the majority are excitatory neurons with pyramidal
or stellate morphology using glutamate as a neurotransmitter. The other class
of neurons are inhibitory local-circuit interneurons with a non-pyramidal shape
that release gamma-aminobutyric acid (GABA) as a neurotransmitter and
comprise 20 to 30 % of all cortical neurons [18, 142]. The balance between
excitatory and inhibitory signaling is crucial for normal cortical maturation,
function and plasticity [138, 139, 130].
Layer I, also termed the molecular layer is devoid of cells and mostly consists of
nerve endings. The upper layers II and III are jointly called the supragranular
layer and are recognized for their abundant pyramidal neurons. Layer IV is
known as the granular layer and includes stellate neurons. The deeper layers
V an VI are denominated together as the infragranular layers and are also
characterized by abundant pyramidal neurons [18].
1.2.3.1 Cortical processing within V1 and the role of pyramidal cells
To optimally process visual information, the di erent layers of V1 are tightly
interconnected and send specific feedforward and feedback projections. The
conventional model of cortical processing (figure 1.2a) formulates that layer IV
neurons are the main target of the thalamus and make short-range connections
to overlying layer II/III neurons which in turn send local and long-range
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connections to neighboring layer II/III, layer V neurons and neurons in higher
order (extrastriate) areas. Subsequently, layer V cells constitute short- and
long-range connections with other cortical layer V neurons and to layers II/III
and VI. In addition, layer V pyramidal neurons project to subcortical areas such
as the SC, striatum, spinal cord and the pons. Finally, layer VI neurons send
feedback signals to all cortical layers and subcortically to the LGN [324, 337].
Recent evidence from the lab of Constantinople and Bruno (2013) challenges
this model by proving that the thalamocortical projection carrying sensory
information not only targets layer IV but also layers V/VI and that layer
V/VI sensory responses do not require layer IV [57]. Therefore they advocate
a bistratified model of cortical processing where the thalamus copies sensory
information to the upper stratum (layer II/III and IV) and the lower stratum
(layers V/VI), allowing parallel processing of sensory information in distinct
anatomical pathways (figure 1.2b) [57].
For the purpose of this dissertation, I will briefly focus on pyramidal neurons,
because this cell type is crucial for integration of interlaminar and interareal
synaptic information and computation [311]. Pyramidal cells are excitatory
neurons characterized by a pyramidal soma and long apical dendrites (figure
1.2c). Oblique dendrites emanate from the main apical dendrite at various
angles. In the cortex, they are located in layers II/III and layer V/VI and
they receive and propagate information through the cortex as mentioned above
[324, 337, 57]. Layer II/III pyramidal neurons have shorter apical dendrites
and more obliques than layer V pyramidal cells [311]. Pyramidal neurons are
often classified in two or three morphological groups based on the length of
the apical dendrite and the appearance of the apical tuft: tall-tufted, tall-
simple and short [186]. However, when taking more parameters into account,
pyramidal neurons appear to have a continuous set of morphologies [183]. In
addition, the extent of dendritic arborization of layer V pyramidal neurons is
species-specific and di ers based on the connections they have and the cortical
area in which they reside [21, 183]. For example, in monkey, the complexity of
the basal dendritic arbors of layer II/III pyramidal neurons increases with the
hierarchical cortical level [94] and in the mouse visual cortex these arbors are
simpler than in the somatosensory cortex [21]. In general, proximal dendrites
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Figure 1.2: Cortical processing models and the general structure of a pyramidal
neuron.
In the conventional model of cortical processing (a) sensory information coming from
the thalamus is serially processed by the LIV-LII/III-LV loop along the densest
axonal pathways (green). The bistratified model (b) proposes a parallel processing
of sensory thalamic information (green) by the upper (LII/III and LIV) and deeper
layers (LV/VI). This model also takes into account the minimal contribution of LII/III
in propagating sensory information to the deeper layers (pink). An essential excitatory
cell type in cortical processing is the pyramidal neuron with a typical layer V neuron
depicted in (c). Adapted from [57, 18].
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receive excitatory input from local sources, whereas the distal part of the apical
dendrite receives input from more distant cortical and thalamic locations [311].
Pyramidal neurons integrate these di erent inputs to compute an output to
the single and highly branched axon typically extending at the base of the
soma [18, 311]. The synaptic and dendritic computation and summation to
provide a final output signal is dependent on various factors, including the
spatial and temporal input pattern and proximal and distal feedforward and
feedback GABAergic inhibition [279, 311, 20, 142, 30]. Important to note is that
layer II/III and V pyramidal neurons send long axons to the contralateral cortex
through the corpus callosum [232]. In addition, a subset of layer II/III and layer
V pyramidal neurons are also multisensory thereby integrating information from
di erent modalities [52, 183].
A vastly studied and intriguing structure on the dendrites of pyramidal neurons
is the dendritic spine, a small protrusion that constitutes the postsynaptic part
of the excitatory glutamatergic synapse [18, 385]. Each pyramidal neuron is
covered with thousands of dendritic spines that vary considerably in size and
shape and are highly plastic [311, 385]. Spines are thought to increase the
dendritic surface to allow more synaptic contacts per unit of dendritic length
[385]. Alteratively, they could serve as distinct biochemical compartments to
restrict the di usion of important synaptic proteins [254]. Spines could also
regulate synaptic currents resulting in altered dendritic integration and the
function of neuronal circuits [254, 330]. However, their fundamental function
remains highly enigmatic and dozens of di erent hypotheses have been proposed
in literature [385, 204].
1.2.3.2 Extrastriate areas
Proper visual perception depends on additional processing of visual information
by areas surrounding V1, called extrastriate areas, which are linked through
feedforward and feedback connections in a hierarchical network [353, 41].
Neurons in these areas are sensitive to discrete aspects of visual information such
as edge orientation, global motion or object motion [207]. Therefore, extrastriate
areas are thought to transform visual information into meaningful information
THE VISUAL SYSTEM OF THE MOUSE 13
about the external environment [41, 354, 253]. Similar to what is widely
acknowledged in primates, recent analysis of cortico-cortical networks suggests
the existence of two specialized visual information pathways in the mouse: a
dorsal and a ventral stream [354, 355, 121]. The dorsal stream is responsible for
the generation of spatial information about object location, motion detection and
visuomotor planning, whereas the ventral stream mainly processes information
to serve object recognition and form representation [294, 124, 18, 355].
Wang and Burkhalter (2007) provided the first complete map of extrastriate
areas in the mouse through a combination of triple pathway tracing, receptive
field recordings and callosal mapping and revealed nine higher areas beyond
V1 (figure 1.3a) [353]. A recent study using intrinsic optical imaging even
revealed eleven extrastriate areas [115] and each extrastriate area is typically
characterized by a complete representation of the visual hemifield [353, 41].
Complementary to these studies, Van der Gucht and colleagues mapped seven
di erent extrastriate areas using immunohistochemistry for non-phosphorylated
neurofilament protein (NF), with a special emphasis on the medial part of the
visual cortex (figure 1.3b) [336]. In addition to NF which is an excellent areal
marker for cortical subdivisions, neuronal activity mapping with zif268 2 mRNA
in combination with monocular and binocular enucleation, elegantly uncovered
the borders between monocular zones, binocular zones and visual and non-visual
cortex [333, 336].
In this dissertation, the extrastriate areas will be termed according to their
eye-input specific functional subdivisions as referred to by Van der Gucht et al.
(2007), Van Brussel et al. (2009) and Nys et al. (2014) [336, 333, 256].
2The gene zif268 encodes for a transcription factor that belongs to the family of immediate
early genes (IEG) that is considered as a reliable and accurate repoter gene for neuronal
activity and has been extensively used to map neuronal activity in the visual cortex [367, 161,
9, 387, 336, 333, 256]. The gene is induced by neuronal activity without any de novo protein
synthesis in the mammalian cortex [161, 177, 256]. One advantage of using zif268 over other
IEGs such as c-fos is that zif268 has a high basal expression and is thus ideally suited for
down-regulation studies [161].
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Figure 1.3: Topographic map of V1 and extrastriate areas.
A retinotopic map of V1 and extrastriate areas is visualized on a flat map of the left
cortical hemisphere (a). The left inset represents the contralateral visual hemifield in
spherical coordinates. Colors indicate di erent quadrants in respect to the horizontal
median (azimuth) and vertical meridian (elevation) and the arrows indicate their
orientation. The binocular field (upper: red; lower: yellow) is highly represented at
the lateral border between LM and V1, whereas the monocular zones are depicted
in green (upper) and blue (lower). All extrastriate areas contain a retinotopic visual
hemifield and adjacent areas contain a topographic mirror-image. A cortical map
based on cytoarchitectural data (b) shows a comparable organization with defined
lateral, medial en anterior extrastriate areas (V2). Abbreviations: A, anterior area;
AL, anterolateral area; AM, anteriomedial area; LI, laterointermediate area; LM,
lateromedial area; PARL, lateral parasubiculum; PARM, medial parasubiculum; P,
posterior area; PM, posteromedial area; POR, postrhinal area; RL, rostrolateral area;
S1, primary somatosensory cortex; Au, auditory cortex; M2, medial motor cortex; MM,
mediamedial area; ENT, entorhinal cortex; RSA, rentrosplenial agranular cortex; RM,
rostromedial area; RSA, rostrosplenial area,; TEA, temporal association area; V2AL,
anteriolateral extrastriate area; V2M, medial extrastriate area; V2PL, posterolateral
extrastriate area. Adapted from [353, 336].
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1.3 Experience-dependent plasticity
Various types of plasticity are present across di erent neuronal networks and
they are able to work in parallel to employ changes both at the neuronal level as
well as the network level [50]. One form of synaptic plasticity was characterized
by Donald Hebb and is nicely summarized by the so-called Hebb’s rule: "neurons
that fire together, wire together" [18]. This rule explains that synchronized
activation between a pre- and postsynaptic neuron increases the synaptic
strength between those neurons and this is termed long-term potentiation
(LTP). The opposing process also exists in which the synaptic e cacy decreases
due to a de-correlated or lack of activation of two neurons and this process
is called long-term depression (LTD). LTP is characterized by an increase
in the number of glutamate sensitive AMPA (–-Amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid) and NMDA (N-methyl-D-aspartate) receptors on the
surface of the dendritic spine which enhances the membrane depolarization upon
presynaptic glutamate release [50, 18]. Concomitant to the increase in synaptic
e cacy, the dendritic spine head enlarges to accommodate more receptors and
this is regulated by underlying cytoskeletal rearrangements (figure 1.5) [145].
Another important kind of synaptic plasticity, called homeostatic plasticity,
maintains network homeostasis by balancing Hebbian plasticity and network
activity to prevent unconstrained potentiation and depression [72, 331, 168].
A major form of homeostatic plasticity is comprised of synaptic scaling in
which the strength of all synapses across a neuron is adjusted compensatory to
the prolonged activity in the network [50]. When the activity in the network
persistently increases, a compensatory decrease in excitatory synaptic strength
will occur and vice versa. This adjustment in global synaptic strength depends
on AMPA receptor tra cking [168] and is regulated by cell adhesion molecules,
growth factors like brain derived neurotrophic factor (BDNF) [331] and signaling
molecules like tumor necrosis factor-– (TNF-–) [164, 331]. Synaptic scaling
in the visual cortex is observed after retinal lesions and accompanies changes
in dendritic spine size on layer V pyramidal neurons [168]. Another form of
homeostatic plasticity is metaplasticity, also called "the plasticity of synaptic
plasticity" in which the prior history of synaptic plasticity for a given synapse
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determines its future potential for plasticity. For example, a synapse that
has undergone LTP is less likely to undergo it again because the treshold for
inducing LTP increases and this process is NMDA receptor-dependent [1, 50].
1.3.1 Ocular dominance plasticity
A classical paradigm to measure plasticity in the visual cortex is by occluding
one eye by means of lid suture or and eye patch and this is termed monocular
deprivation (MD). The outcome of this disturbance in visual input can be
determined in the binocular zone of the visual cortex, where the inputs from
the two eyes first converge and compete for space [139, 96]. Neurons in the
binocular zone respond in a di erent degree to visual stimuli presented to one
eye or the other and this property is called ocular dominance (OD) [23, 139].
Performing MD causes visual cortical neurons to become dominated by the
nondeprived eye and this OD plasticity is highest during a critical period in
postnatal development which declines with age [22]. A complete OD shift
underlies various forms of plasticity such as Hebbian and homeostatic plasticity,
which act in concert [96]. Important to note is that the shift in OD occurs in V1
and not in earlier processing centers, which makes this paradigm ideal to study
cortical plasticity mechanisms [96, 362]. The study of OD plasticity by means
of MD can serve as a model to study vision disorders such as amblyopia or "lazy
eye" where misaligned or unbalanced eye input disturbs OD [139]. Investigating
age-dependent OD plasticity can open new avenues to treat this type of vision
disorder later in life. In the last decade, considerable knowledge has been
obtained about the factors regulating OD plasticity, including GABAergic
intracortical inhibition, epigenetics, and Hebbian and homeostatic plasticity
mechanisms [77, 310, 299, 130, 96].
1.3.1.1 Extracellular matrix and structural plasticity
The interstitial space between neurons is filled with a matrix of crosslinked
molecules that are in turn bound with membrane molecules. This extracellular
matrix (ECM) determines the mechanical and functional properties of neurons
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and can influence intracellular signaling pathways. Key components of the
brain ECM are chondroitin sulphate proteoglycans (CSPGs) which condense
into lattice-like structures called perineuronal nets (PNN) [79]. In the visual
cortex these PNN mostly surround fast-spiking inhibitory interneurons but
also pyramidal neurons [7] and their formation coincides with the end of the
critical period for OD plasticity [277, 23]. Degradation of CSPGs with the
bacterial enzyme chondroitinase ABC reactivates OD plasticity in adult MD
rats [277] and this implies that maturation of PNN restricts synaptic plasticity
in the visual cortex [277, 166, 66]. In accordance, one of the functions of
PNN is to compartmentalize AMPA receptors and restrict receptor mobility
at the synapse [112, 166], hence regulating LTP and LTD mechanisms [166].
Concomitantly, the ECM is able to regulate structural plasticity by altering
cytoskeletal dynamics and this aspect is recognized as an important regulator
of critical period plasticity [263, 139, 221]. Regulation of cytoskeletal dynamics
includes the rearrangement of the actin, tubulin and neurofilament framework
to enable motility and plasticity of neurites and spines [131, 145, 383]. During
the critical period, two days of MD elicits a transient increase in the level of the
extracellular serine protease tissue plasminogen activator (tPA) [210] and tPA
is necessary for the concomitant increase in dendritic spine motility on layer
II/III and V pyramidal neurons contralateral to the deprived eye [263]. After
four days of MD a reduction in spine density is observed on neurons serving
the deprived eye and this is also reflected by a complete loss of functional
response. This spine motility and pruning only occurs in the binocular zone,
not the monocular zone, and serves as an anatomical substrate to re-establish
the competitive balance between the two eyes [139].
1.3.2 Monocular enucleation-induced cross-modal plasticity
In contrast to MD, monocular enucleation (ME)3 or the removal of one eye
completely eliminates retinal input and can be considered as a model for
irreversible unilateral dea erentiation to study both visual and cross-modal
plasticity. Cross-modal plasticity entails that when the input of one sensory
3Whereas ME completely eliminates retinal input, spontaneous retinal activity still persists
with MD and di use light can still hit the retina when applying MD by lid suture [2, 257].
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modality disappears, the deprived cortical neurons get recruited by the remaining
modalities by functional and structural reorganization and in turn, the function
of the remaining modalities strengthens to compensate for the sensory loss [17].
It is indeed accepted that for example, when an individual loses vision, their
somatosensory and auditory capabilities are altered. For the purpose of this
manuscript I will focus on studies performed in our lab to address cross-modal
plasticity in the mouse visual cortex using the ME paradigm.
Van Brussel et al. (2011) revealed that cortical reactivation after long-term
ME has a partial non-visual component in adult mice of postnatal day (P) 120
[334]. Indeed, in contrast to short-term ME, which induces a marked reduction
in neuronal activity in the contralateral visual cortex (figure 1.4a,b), P120 mice
seven weeks after ME (7wME) displayed zif268 expression levels comparable to
those of age-matched control animals along the complete mediolateral extent
of the visual cortex (figure 1.4a,c). In the first weeks post-ME, open-eye
potentiation drives reactivation from the binocular zone outwards [101, 256]
and from three weeks onwards cross-modally driven reactivation occurs in
the adjacent lateral (V2L) and medial monocular (V1 and V2M) areas [334].
Two key experiments revealed that this latter reactivation process was indeed
cross-modally driven. First, whisker stimulation in complete darkness in 7wME
mice revealed zif268 expression in V2M. Second, whisker trimming of 7wME
mice abolished the observed zif268 signal in all monocularly driven zones. A
follow-up study by Nys et al. (2014) disclosed that this potential for cross-modal
plasticity is age-dependent [256]. When performing ME on adolescent (P45)
mice, an age characterized by the largest change in visually controlled genes
post-ME [203], the cross-modal reactivation of the visual cortex appeared to be
lacking 7w post-ME (figure 1.4d). Moreover, when comparing 7wME in P45,
P90 and P120 there was a gradual increase in the reactivation along the full
mediolateral extent of the visual cortex with only P120 7wME zif268 expression
reaching control levels. To conclude, ME in the mouse provides a valuable
model to study age-dependent cross-modal plasticity.
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Figure 1.4: ME-induced cortical reactivation in P120 and P45 mice.
Radioactive in situ hybridization for the neuronal activity marker zif268 enables the
visualization of neural activity across all layers of the visual cortex with a darker
signal representing higher zif268 expression and thus higher neuronal activity. Mice
with both eyes intact exhibit high zif268 expression along the entire mediolateral
extent of the visual cortex (a). Performing monocular enucleation (ME) or the removal
of one eye induces a vast decrease in neuronal activity in the contralateral visual
cortex with residual zif268 expression in the binocular zone serving the remaining
eye (b). Interestingly, in adult (P120) mice seven weeks post-ME (7wME) the
contralateral visual cortex displays an extensive reactivation which is caused by both
the potentiation of the remaining eye which drives reactivation from the binocular
zone (letter b) outwards, and cross-modal plasticity which reactivates the medial and
lateral monocular areas (letter m) (c). The potential for cross-modal plasticity is age-
dependent since adolescent (P45) mice do not exhibit reactivation in the monocularly
driven areas at 7wME (d). Abbreviations: V2L lateral extrastriate cortex; V2M,
medial extrastriate cortex; V1, primary visual cortex. Adapted from [256].
20 GENERAL INTRODUCTION
1.3.3 Cytoskeletal dynamics in neuroplasticity
As briefly discussed in section 1.3.1.1, structural plasticity relies on the
underlying dynamics of the cytoskeleton, composed of an interwoven network
of actin filaments, microtubules and intermediate filaments (figure 1.5).
Neurofilament proteins, a type of intermediate filaments, form a structural
matrix that embeds microtubules, which transport cargo (e.g. proteins
and organelles such as mitochondria) along the neurite and synapses [107].
Neurofilaments are composed of four subunits called heavy (NF-H), medium
(NF-M) and light (NF-L) chains, and –-internexin (NF-66) [382]. A number
of di erent roles have been identified for neurofilaments. In addition to
maintaining neuronal structure, they are particularly abundant in axons and
determine the axon diameter which is correlated with the axons conductivity
[383]. Neurofilaments are also crucial for docking cellular constituents such
as mitochondria [201]. Indeed, it has been shown that neurofilaments
bind to mitochondria for proper allocation to energy-demanding synapses to
modulate synaptic plasticity [350, 201]. Considerable attention has gone to
the phosphorylation state of NF since this induces axonal radial growth and
hyperphosphorylation of NF slows down their transport along microtubules,
causing NF accumulation in the soma, which is a hallmark of neurodegenerative
diseases such as amyothropic lateral sclerosis and Alzheimer’s disease [67, 15].
Important to note is that the majority of phosphorylated NF is located in
the axons, whereas dephosphorylated NF is primarily found in dendrites [383].
Finally, the stoichiometry of the di erent NF subunits is essential for proper
functioning of the cytoskeleton since overexpression of NF-H and NF-M can
induce NF aggregation whereas this is rescued by additionally overexpressing
NF-L [179].
The main function of microtubules is to regulate long-range transport through
interaction with the molecular motors dynein and kinesin that bind to cargo
such as proteins, lipids, mitochondria and lysosomes [128]. However, both
microtubules and actin filaments serve additional functions, especially in
dendritic spines where they regulate spine stability and plasticity, receptor
tra cking and docking of organelles [219, 145, 201]. The dynamics of actin
cytoskeleton are well characterized in dendritic spines and are regulated by an
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array of actin-binding proteins, such as the Arp2/3 complex, WAVE1, cortactin,
profilin and cofilin (figure 1.5) [98]. The Arp2/3 complex promotes actin
branching and regulates spine head growth, whereas WAVE1 and cortactin
activate the Arp2/3 complex and influence spine density [98, 145]. Both profilin
and the actin depolymerizing factor cofilin modulate spine head morphology
and spine size during LTP [80, 145].
1.4 Mitochondrial dynamics and autophagy
Most of the energy consumed by the brain is generated by mitochondria in
the form of ATP by processing oxygen and glucose-derived substrates. To
e ectively distribute this energy, mitochondria are continuously transported
along the microtubule network to energy-demanding locations such as the pre-
and post-synapse [280, 201]. Mitochondria are able to sequester cytoplasmatic
calcium and therefore their location and abundance can modulate neuronal
signaling and synaptic plasticity [49, 201]. In addition, mitochondria can control
synaptic plasticity by the production of reactive oxygen species (ROS) that act
as signaling molecules which are necessary for LTP and activation of NMDA
receptor downstream targets [175]. To control number, morphology and size and
to maintain their health, mitochondria continuously undergo fission and fusion
which mixes mitochondrial DNA and metabolites [74, 201]. This process is
regulated by dynamin-related protein 1 (Drp1) and fission protein 1 (Fis1) which
mediate mitochondrial fission, whereas mitofusins (Mfn-1 and Mfn-2) and Optic
Atrophy-1 (OPA-1) mediate mitochondrial fusion (figure 1.6) [74]. Numerous
processes in the brain including dendritic growth and branching, spinogenesis,
spine morphology and synaptic plasticity depend on proper mitochondrial
dynamics and function [192, 49, 35].
Another way to control energy distribution in neurons is by mitophagy or
the degradation of mitochondria by a process called autophagy. In fact,
autophagy is an evolutionarily highly conserved cellular homeostatic process
whereby cells control their cytoplasmic biomass, organellar abundance and
distribution, and remove potentially harmful protein aggregates [70]. Several
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Figure 1.5: Cytoskeletal organization in dendrites.
Microtubules serve as railways for long-range transport via kinesin (anterograde
transport, towards the plus-end) and dynein (retrograde transport, towards the minus-
end) motors which attach cargo such as mitochondria through adaptor proteins.
Neurofilament proteins shape the neuronal structure and regulate the docking of
organelles at specific sites such as the dendritic spine. In the dendritic spine, the actin-
based cytoskeleton can modulate rapid changes in growth and shape by branching
and (de)polymerization, which is regulated by proteins such as the Arp2/3 complex
and WAVE1. In addition, the actin cytoskeleton can facilitate docking and entry of
organelles into the spine and it regulates the clustering and tra cking of membrane
molecules such as AMPA and NMDA receptors. Adapted from [201].
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Figure 1.6: Mitochondrial fission and fusion.
Mitochondria continuously undergo fission (a) and fusion (b) to maintain their health.
Fission is regulated by dynamin-related protein 1 (Drp1) which oligomerizes around
the outer mitochondrial membrane and is recruited by fission protein 1 (Fis1). Full
oligomerization of Drp1 creates spiral chains that wrap around mitochondria and
complete fission. Fusion is accomplished by dimerization of mitofusin-1 and -2 (Mfn-
1/Mfn-2) and Optic Atrophy-1 (OPA-1) which completes outer and inner membrane
fusion respectively. Adapted from [201].
24 GENERAL INTRODUCTION
neurodegenerative diseases are characterized by defective autophagy and failure
to remove harmful protein aggregates [384, 48]. Autophagy is dynamically
regulated by starvation and other stress factors and is initiated through
sequestering organelles and proteins in spherical membrane structures called
autophagosomes. Eventually, autophagosomes fuse with lysosomes containing
hydrolases to form autolysosomes that degrade the sequestered material (figure
1.7) [384]. The formation of the autophagosome membrane is regulated by
an array of autophagy-related proteins (Atg) and the microtubule-associated
protein 1 light chain 3 (LC3) [230, 322, 388]. Two forms of LC3 exist: cytosolic
LC3-I and phosphatidylethanolamine-conjugated LC3-II which inserts in the
autophagosome membrane. Conversion of LC3-I to LC3-II is indicative for the
formation of autophagosomes [322, 35]. Importantly, because LC3-II is both
present in the outer and inner part of the autophagosome membrane, LC3-II
itself gets partially degraded in autolysosomes (figure 1.7). Therefore, assessment
of LC3-I and LC3-II levels is often combined with the use of lysosomal inhibitors
to determine the rate of autophagy, also called the autophagic flux [229, 322].
Figure 1.7: The process of autophagy.
Autophagy is initiated by the formation and elongation of an autophagosome
membrane to form autophagosomes that capture proteins and organelles. This process
is regulated by autophagy-related proteins (Atg) and phosphatidylethanolamine-
conjugated LC3-II which insert in the membrane. Next, autophagosomes fuse
with lysosomes containing hydrolases to form autolysosomes which degrade the
sequestered material, thus completing the autophagic process. Adapted from
http://ruo.mbl.co.jp/e/product/protein/lc3.html
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1.5 Matrix metalloproteinases
More than fifty years ago, a new field in biomedical research arose when
in 1962 Jerome Gross and colleagues described an interesting collagenolytic
activity during metamorphosis in tadpoles [126]. This activity turned out to
be interstitial collagenase, the first member of the enzyme family called matrix
metalloproteinases (MMPs) and in the following decades, much more members
were discovered. MMPs are in fact Zn2+-dependent endopeptidases that touch
almost every aspect of normal and pathological mammalian biology from egg
cell fertilization, embryonic development, tissue repair, immune and nervous
system function to cancer, inflammation, autoimmune diseases, vascular diseases
and neurodegenerative disorders [377, 33, 97, 5]. They tightly regulate cell
behavior in these processes by modulating the extracellular matrix, hormones,
cytokines, chemokines, adhesion molecules, growth factors, receptors and an
array of intracellular substrates [295, 40].
1.5.1 Number, structure and classification
The number of distinct MMPs di ers between species. For example, C. elegans
only has three MMPs [106], Arabidopsis thaliana has five [206] and both humans
and mice have 23 di erent MMPs [209, 156]. For the number of MMPs in human
and mice, slightly contradictory literature is present. Yong et al. (2005) state
that humans possess 24 MMPs and mice 23 because they claim that humans
have two di erent forms of MMP-23 (A and B) [377]. In fact, human MMP-23A
is encoded by a pseudogene and thus cannot be regarded as a functional MMP
protein. Therefore, both humans and mice possess 23 MMPs with the only
di erence that mice have two subtypes of MMP-1(ColA and ColB) and lack
the orthologue of human MMP-26 [377, 156].
MMPs are multidomain enzymes characterized by a highly conserved catalytic
domain with three histidine-residues binding a central Zn2+ ion [377, 40]. In
general, the structure of a typical MMP consists of an N-terminal signal peptide,
a prodomain, a catalytical domain, a linker or hinge region, and a C-terminal
hemopexin-like domain (figure 1.8). MMPs are synthesized as pre-proenzymes
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and the signal peptide that targets the enzyme to the endoplasmatic reticulum
is removed during translation. The prodomain contains a conserved cysteine
residue with a thiolgroup that interacts with the Zn2+ ion of the catalytic site to
maintain the latency of the enzyme [246]. The catalytic domain dictates cleavage-
site specificity through its active site cleft, subsite pockets that interact with
amino acids adjacent to the peptide scissile bond and through substrate-binding
exosites located outside the active site [265, 314]. The hinge region makes the
MMP extremely flexible for the proper positioning of the catalytic domain
relative to the hemopexin-like domain to e ciently interact with substrates
[264]. The C-terminal hemopexin-like domain is necessary for protein-protein
interaction and contributes to substrate specificity and regulation of enzyme
activity by interacting with specific substrates and endogenous inhibitors [349,
276]. Moreover, MMPs can act as ligands through their hemopexin-like domain,
thereby initiating downstream signal cascades by binding to receptors [152, 276].
Exceptions to this general domain structure are MMP-7 (matrilysin), MMP-
26 (endometase/matrilysin-2) and MMP-23, which lack the hinge region and
hemopexin-like domain. Instead, the C-terminal of MMP-23 consists of unique
cysteine-rich, proline-rich, immunoglobulin-like, and IL-1 type II receptor-like
domains. MMP-2 (Gelatinase A) and MMP-9 (Gelatinase B) have gelatin-
binding fibronectin-like domains to e ciently interact with gelatin and gelatin-
like substrates. Finally, there are four membrane-type MMPs (MMP-14, -15,
-16 and -24) characterized by a transmembrane domain and other MMPs have
a glycophosphatidyl inositol (GPI) membrane-anchoring signal (MMP-17 and
MMP-25).
Di erent classifications of MMPs exist in literature [293, 269, 349, 97, 152]
and one popular way to classify them is based on their domain composition.
Nevertheless, little consensus about this classification is present in the field since
domain structure does not predict function. Other types of MMP organization
entail the subdivision based on activation mechanism, substrate preference or
cellular localization. A combination of these classifications is presented in figure
1.8.
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Figure 1.8: Classification of matrix metalloproteinases.
This overview shows the general domain structure of MMPs. MMP-7 and -26 are
minimal domain MMPs because they lack the hinge region and hemopexin-like domain.
Certain MMPs contain a furin-cleavage site (Fr) for intracellular activation and a
subset of these MMPs are membrane-anchored and characterized by a transmembrane
(TM) domain, glycophosphatidyl inositol (GPI) anchor (MMP-17 and -26) or an amino
(N)-terminal signal anchor (SA) (MMP-23). MMP-2 and -9 are distinctive for their
fibronectin-like (Fn) domains to bind gelatin e ciently. Abbreviations: C5, type-V-
collagen-like domain; Col; collagenase-like protein; Cs, cytosolic; Cys, cysteine array;
Fn, fibronectin repeat; Fr, furin-cleavage site; IgG, immunoglobulin; Pro, pro-domain;
SH, thiol group; SP, signal peptide; Zn2+, zinc ion. Adapted from [269].
1.5.2 Regulation of MMP activity
To perform their function optimally in both normal and pathological conditions,
MMPs must be present in the right cell type, the correct (peri)cellular
location, at the right time, in the right amount, and they must be activated
or inhibited appropriately. Therefore they are tightly regulated at di erent
levels: transcription, compartmentalization on or near the cell surface, zymogen
activation, and enzyme inactivation/degradation [269, 97]. The final catalytic
activity is further determined by substrate a nity and availability.
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1.5.2.1 Transcription
MMP promotors harbor several cis-elements allowing for a precise regulation of
gene expression by a variety of transcription factors [314, 374]. Several MMPs
share cis-elements suggesting that these MMPs are transcriptionally regulated
together [374]. One major regulator of MMP gene expression is the transcription
factor activator protein-1 (AP-1) which consists of Fos family and Jun family
protein heterodimers [359, 314]. Most MMP-genes contain an AP-1 site and
a classic TATA box at the promotor site, exceptions being MMP-8, -11 and
-21 which lack the AP-1 site. MMP-2, -14 and -28 lack both the AP-1 site and
TATA box. The presence of an AP-1 site renders the MMP-genes responsive to
inducible factors such as cytokines and growth factors, including interleukins,
interferons, TNF-–, and the extracellular matrix metalloproteinase inducer
EMMPRIN [314, 374]. Moreover, several factors including growth factors,
cortisol and integrins can also modulate post-transcriptional mRNA levels by
directly stabilizing or destabilizing the mRNA thereby influencing its half-life
[374]. In addition, alternative splicing and promotor usage can further determine
the net MMP activity. For instance, MMP-11 can be translated directly as
an active enzyme through an alternative transcript lacking the signal peptide
and prodomain [200]. Another example of the complex regulation of MMP
activity at the level of transcription is presented by the observation that nuclear
MMP-3 is able to act as a transcription factor for the connective tissue growth
factor (CTGF) gene in chondrocytes [92]. CTGF in turn increases transcription
of MMP-1, -2, -3, -7 and -14 [45, 40]. Additionally, CTGF itself serves as a
substrate for these MMPs which can terminate the positive feedback loop [68].
In this way, MMPs are able to influence the level of their own transcription.
In the adult human and rodent brain, a wide range of MMPs have low
mRNA levels and transcription is mainly upregulated during early postnatal
development [152]. However, MMPs are transcriptionally upregulated in reponse
to neuronal activity, injury and neurological disorders [180, 225, 152, 114]. For
example, MMP-9 mRNA levels increase in the rat hippocampus in reponse to
systemic administration of the glutamate receptor agonist kainate [318].
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1.5.2.2 Compartmentalization
Confinement of MMP proteolysis to certain cellular compartments is essential
to maintain catalytically favorable levels of both enzyme and substrate [327].
Moreover, undirected release of an active MMP could lead to an unwanted
degradation cascade [285, 327]. It remains a key question in MMP biology
of how specific proteinase-substrate interactions are regulated to limit MMP
action to specific, targeted substrates since this determines a large part of MMP
specificity [285]. One possible mechanism to ensure a su ciently high enzyme
concentration within the proximity of the desired substrate is by confining MMPs
to pericellular niches by anchoring to the cell membrane or by interaction with
extracellular macromolecules [314, 97, 285].
The membrane bound MMPs (MT-MMPs) can be concentrated to specific
cell surface locations by partition into lipid rafts and for example MT1-MMP
(MMP-14) can form a tripartite complex with proMMP-2 and an endogenous
inhibitor to locally activate the latent MMP-2 molecule [71, 314]. In addition
to the compartmentalized nature of MT-MMPs, several observations of MMP-
cell interaction have been reported such as MMP-7 that is able to anchor to
cholesterol and surface proteoglycans [381], and MMP-9 to surface proteoglycans
[381] and the hyaluronic acid receptor CD44 [380]. Anchoring to integrin
receptors has been shown for MMP-1 [87] and MMP-2 [71]. Direct MMP
activation by allosteric interaction with these receptors and extracellular
macromolecules can influence the level of local catalytic e ciency, thereby
adding another level to compartmentalize MMP activity [327]. MMPs can also
undergo di erent cell sorting by an ine ciently translated signal peptide or
loss of this peptide by alternative splicing [92, 40]. In addition, endocytosis
provides a mechanism to recycle and relocate MT-MMPs (e.g. MMP-14) [290]
and to transfer exogenous MMPs to the cytosol (e.g. MMP-3 and MMP-7)
[328, 319], which can then further travel to the nucleus (e.g. MMP-3) [307, 92].
Finally, recent evidence shows that MMP-9 mRNA is transported to dendrites
in hippocampal neurons and is locally translated in response to glutamate
stimulation [152, 89].
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1.5.2.3 Zymogen activation
MMPs are mostly synthesized as inactive zymogens and their latency is
maintained by a cysteine in the prodomain that interacts with the catalytic
Zn2+ ion and forms a complex that blocks the active site. MMPs can undergo
a direct or stepwise activation (figure 1.9), which results in the dissociation of
the cysteine residue from the complex, a process called the "cysteine switch"
[340]. An important aspect of the cysteine switch mechanism is that the
prodomain does not necessarily need to be removed to acquire an active enzyme
[285]. Generally, there are three main activation mechanisms that can be
distinguished: 1) a direct proteolytic cleavage of the prodomain, 2) a non-
proteolytic modification of the cysteine residue and 3) an allosteric perturbation
of the zymogen by binding to a receptor or substrate [285, 304, 40]. In addition,
translation of alternative spliced mRNA lacking the prodomain can directly
yield active MMPs (see previously) [200, 40].
Non-proteolytic activation results in the destabilization of the cysteine-Zn2+
coordination and gives rise to a partially activated MMP intermediate [243]. The
final step involves the action of an MMP or its intermediate, meaning that MMPs
can activate each other [243, 349]. Proteinases such as furin and MMPs, low pH,
high temperatures and chemical agents such as 4-aminophenylmercuric acetate
(APMA), detergents (e.g. SDS), heavy metals, alkylating agents, oxidants (e.g.
ROS) and reactive nitrogen species (NOS) can activate MMPs [349, 285]. Non-
proteolytic activation may lead to subsequent autoproteolytic degradation of the
propeptide resulting in autocatalytic activation of the MMP [343]. Interestingly,
Tocchi et al. (2013) reported an interaction between MMP-7 and its CSPG
substrate that augments the autocatalytic activity of the enzyme, demonstrating
that substrate binding can impact MMP activity by allosteric perturbation of the
zymogen. Importantly, allosteric activation mechanisms have been characterized
for several MMPs [365, 285, 327].
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Figure 1.9: Activation mechanisms of proMMPs.
MMPs are synthesized as inactive zymogens (proMMPs) and are most commonly
activated by direct proteolytic cleavage of the prodomain which yields mature MMPs.
Non-proteolytic agents can disrupt the catalytic cysteine-Zn2+ coordination which
results in partially active MMPs that can undergo autocatalysis or proteolysis by other
MMPs to form mature MMPs. Binding to a receptor or substrate can distort the
catalytic domain which leads to allosteric activation. In addition, alternative splicing
may yield MMP transcripts lacking the signal peptide and prodomain which translate
into constitutively active enzymes. Adapted from [40].
1.5.2.4 Endogenous MMP inhibition
In the blood and lymphatic system MMPs are inhibited by –2-macroglobulin
whereas in mammalian brain tissue the endogenous inhibitors constitute four
members of the tissue inhibitors of metalloproteinase (TIMP) family [97]. TIMP
expression corresponds to the expression of MMPs and they bind MMPs in a 1:1
stochiometry so an imbalance in expression can significantly e ect overall MMP
activity [5]. The N-terminal domain of the TIMP interacts with the catalytic
domain, whereas the C-terminal domain interacts with the MMP hemopexin
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domain and both interactions determine the inhibitory specificity. For example,
TIMP-1 inhibits MMP-3 and MMP-9 more readily than MMP-2, which is mostly
inhibited by TIMP-2 [314, 97]. Paradoxically, TIMP-2 is necessary for proper
activation of proMMP-2 in vivo by binding to MMP-14 and proMMP-2 [314].
In normal, unstimulated adult CNS the expression of TIMP-1 is low whereas
TIMP-2 and -3 are expressed more abundantly by neurons and astrocytes
[97, 227]. TIMP-4 is exclusively expressed in the cerebellum and dorsal root
ganglia with increased expression into adulthood [227]. Besides inhibition of
MMPs, TIMPs have MMP-independent functions such as regulating cell growth,
cell survival, apoptosis and neurite outgrowth by binding to various cell surface
receptors [305, 315, 323]. In addition, other molecules with MMP inhibiting
properties have been described such as the —-amyloid precursor protein which
can inhibit MMP-2 [141, 245].
1.5.3 Functions in the CNS
Subsets of MMPs and TIMPs are expressed in the CNS by many cell types
including neurons, astrocytes, microglia, vascular endothelial cells and choroid
plexus epithelial cells [227]. In accordance to their widespread expression
profiles, MMPs are implicated in a myriad of CNS pathologies and are necessary
for normal brain development and function [378, 5]. For the purpose of this
dissertation, I will mainly focus on the functions of MMPs in neurite outgrowth
and guidance, and plasticity.
1.5.3.1 Neurite outgrowth and guidance
MMPs regulate neurite extension and guidance in various ways. For example,
MMPs regulate the signaling of the axonal chemoattractant netrin-1, by
ectodomain shedding of netrin-1 receptors. Netrin-1 and its receptor are required
for proper axon outgrowth, branching and guidance [220, 69]. Other classes
of guidance molecules are also susceptible to MMP processing. Ectodomain
cleavage of the Ephrin-B2 receptor by the gelatinases MMP-2 and MMP-9
induces growth-cone collapse both in vitro and in vivo [193]. In addition,
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semaphorin-3A (Sema3A)-induced dendritic outgrowth of cortical neurons is
regulated by MMP-2 [122] and Sema3A negatively regulates the expression of
MMP-3 [123]. Moreover, the growth-promoting e ect of Sema3C on cortical
axons requires MMP activity [123].
Neurite outgrowth can also be regulated by MMPs through the activation of
growth factors such as nerve growth factor (NGF), insulin-like growth factor
(IGF) and BDNF. BDNF and NGF are involved in axonal outgrowth in vitro
and in dendritic growth in the visual cortex [213, 199] and both growth factors
are known substrates of MMPs [188, 227]. IGF-1 stimulates the growth of
dendrites in the somatosensory cortex [251] and proteolytic activity of MMPs
is required to regulate the bio-availability of IGF-1 through cleavage of IGF-
binding proteins (IGFBPs) [109, 53]. Another mechanism by which MMPs
can influence neurite outgrowth is through the processing of growth inhibiting
CSPGs. MMPs can degrade these proteoglycans to make the ECM permissive
for neurite outgrowth [391]. Conclusively, MMPs can be considered as important
mediators of neurite outgrowth and guidance.
1.5.3.2 MMPs and neuroplasticity
MMPs are capable of remodeling synaptic circuits and are vital for behavioral
and experience-dependent plasticity [152]. For example, an important modulator
of hippocampal synaptic plasticity is MMP-9, which is essential for late-phase
LTP [247, 260, 356, 360] and regulates dendritic spine dynamics through —1-
integrin signaling [356, 80, 224, 312]. In accordance, MMP-9 null mice have
defects in late phase LTP and this hippocampal phenotype is rescued by
application of MMP-9 [247, 227]. MMPs can also modulate the induction of LTP
[182] by processing growth factors such as BDNF [188, 227]. Moreover, several
actin-binding proteins including Arp2/3, cortactin and cofilin are putative MMP
substrates and have been implicated in MMP-mediated structural plasticity
[216, 80, 40].
At the level of behavior, Meighan et al. (2006) found that expression of
hippocampal MMP-3 and MMP-9 was transiently increased in rats during Morris
water maze acquisition and this process was NMDA receptor-dependent. Infusion
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of an MMP inhibitor impairs their learning ability and a ects the expression of
the dendritic cytoskeletal protein cortactin [216]. Another important study was
done by Wright et al. (2009) in which MMPs were inhibited during habituation
learning, resulting in the inability of rats to habituate to a stimulus-induced
head-shake response and this e ect was found to be largely specific to MMP-
3 [369]. In addition, MMP-3 is also necessary for memory consolidation in
fear-conditioning [262] and several other studies also indicate that MMPs are
implicated in learning and memory [178, 114]. In summary, a large body of
evidence implicates several MMPs in structural and functional plasticity in the
hippocampus and striatum. However, much less is known about their function in
cortical plasticity. General MMP inhibition was recently reported to selectively
prevent the potentiation of the open-eye after 7 days of MD in the visual cortex
of juvenile rats [309]. In this model, MMP inhibition mainly a ected the spine
dynamics of layer II/III pyramidal cells in the binocular zone, indicating that
MMPs are necessary for experience-dependent structural plasticity [309]. Also,
MMP-9 knockout mice are characterized by a decrease in experience-dependent
plasticity of the barrel cortex upon sensory deprivation [163]. Tiraboschi and
colleagues recently discovered that reinstatement of OD plasticity in adult rats
invokes an upregulation of MMP-2 and MMP-9 genes, possibly contributing to
the required structural plasticity [326]. It is assumed that MMPs are also able
to influence cortical plasticity in various ways, for example by modulating PNN,
which are composed of CSPGs. CSPGs are known substrates of several MMPs,
especially MMP-3 [239, 237] and enhanced expression of MMP-2 and MMP-9
coincides with a reduction of PNN in the cerebellum during environmental
enrichment [108]. Moreover, Mataga and colleagues showed that the serine
protease tPA is upregulated in V1 after two days of MD and is necessary for
structural OD plasticity, which provides direct evidence that visual cortex
plasticity is dependent on extracellular proteolytic activity [210]. Interestingly,
tPA is able to activate several MMPs [243, 349], providing a potential mechanism
by which MMPs could exert an e ect on OD plasticity [309]. MMPs could also
be involved in cortical plasticity through regulating the bio-availability of IGF-1
or TNF-– signaling. IGF-1 has been reported to modulate GABAergic inhibition
in environmental enrichment and OD plasticity paradigms [51, 212], whereas
TNF-–, just as BDNF, is essential for homeostatic plasticity [164, 96] and can
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be activated by several MMPs [116, 314]. To conclude, it is well-established that
MMPs are important mediators of various forms of neuroplasticity although
their exact mechanisms of operation still remain elusive.
1.5.4 MMPs as therapeutic targets
Over 25 years ago, MMPs were thought to be primarily implicated in the
degradation of the ECM between tumor cells and blood vessel linings to
promote cancer progression [341, 120]. Therefore, the first clinical trials
were set up to try to inhibit MMP activities in metastatis and angiogenesis
[266]. At that time, only three MMPs were characterized and their function
was thought to be merely detrimental. As highlighted previously, the MMP
biology has become far more complex since then and over the years it has
been established that MMPs, despite their detrimental role in a myriad of
diseases, are vital for the normal development and functioning of the brain,
other organs and even an entire organism [5]. The dual role of MMPs is apparent
in for example cerebral ischemia or stroke where MMPs first cause blood-brain-
barrier disruption and inflammation whereas in later stages they promote
angiogenesis and are necessary for functional recovery by promoting brain
plasticity [61, 5]. Also in cancer several MMPs are able to prevent metastasis
by cleavage and inactivation of chemokines [266]. Therefore in retrospect, it
is not surprising that almost all broad spectrum MMP inhibitors (MMPI)
and even the more specific ones, failed in extensive phase III clinical trials
[33, 58, 265]. Failure of these clinical trials can be explained by several reasons,
including: poor oral bioavailability, metabolic instability, insu cient specificity,
dose-limiting toxicity and inadequate spatial and temporal administration of
MMPIs [58, 105, 341]. In addition, because crucial di erences exist between the
protease and substrate degradomes of mice and humans, discrepancies between
the e ects of MMPIs in preclinical mice experiments and human clinical trials
undermined the therapeutic potential of these MMPIs [266, 341]. Early clinical
trials with prolonged application of broad-spectrum MMPIs revealed unwanted
side-e ects such as musculoskeletal pain and inflammation, indicating the need
for more specific MMPIs [85]. To date, only one MMPI (Periostat, doxycyline)
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past clinical phase III and was approved by the FDA to be used in periodontitis
[267].
A major obstacle in MMPI research is to synthesize specific, potent MMPIs for
any of the known MMPs because of similarities in their catalytic cleft, although
promising advancements are being made [265, 88, 75, 65]. One of the most
important aspects for the future success of MMPIs is a complete characterization
and validation of the MMP targets and antitargets in a specific physiological
process. Only then will we be able to inhibit MMPs with the greatest e cacy
in a spatially and temporally controlled manner.
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38 MMP-3 DEFICIENT CORTICAL PHENOTYPE
2.1 Introduction
The capacity of the mammalian brain to change its functional and anatomical
organization based on sensory experience is defined as neuroplasticity. To ensure
a correct development of sensory systems, genetically determined molecular
programs control the formation of connections that are further sculpted by
neural activity and are able to adapt after injury or sensory manipulation
through experience-dependent plasticity [271, 310]. The visual system is the
prime model for studying brain plasticity, including changes in deprived as
well as non-deprived areas in response to sensory impairment, referred to as
cross-modal plasticity. In the visual cortex of adult mice we recently revealed
a potential for cross-modal plasticity following monocular enucleation (ME)
[334, 256]. We provided evidence for an extensive reactivation of the visual
cortex within 7 weeks post-ME. This reactivation was driven by an initial
open-eye potentiation followed by cross-modally driven plasticity in the medial
an lateral monocular zones starting from adjacent non-visual cortices around 3
weeks post-ME [334]. However, the molecular determinants regulating these
two distinct plasticity processes still remain unclear. In that regard, matrix
metalloproteinases (MMPs), Zn2+-dependent endopeptidases that modulate
extracellular matrix proteins, chemokines, cytokines, growth factors, receptors
and a range of intracellular substrates, have over the years been identified as
major regulators of normal brain development and neuroplasticity [377, 97, 40,
205]. Indeed, it is well established that MMPs are necessary for proper axon
guidance and elongation [123, 261], neurite remodeling [143, 339, 225, 376],
dendritic spine dynamics and elongation [318, 143, 224], synaptic plasticity [90,
225] and learning and memory [247, 216, 369]. Several MMPs, including MMP-3,
are expressed in the cortex both under normal and pathological conditions such
as stroke [308, 123, 227, 122]. Moreover, it has been shown that MMP-3 is
necessary for proper cortical axon extension and guidance through interaction
with semaphorin-3A and -3C [123]. MMP-3 is able to cleave and activate several
other MMPs [258, 240] including MMP-9, which is a major regulator of dendritic
spine dynamics, and late-phase LTP [318, 223, 224]. Recently, Spolidoro et al.
(2012) uncovered a role for MMPs in critical period plasticity of the visual cortex
in monocular deprived (MD) rats. Infusion of a broad-spectrum MMP inhibitor
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prevented both the potentiation of the open-eye response and the increase
in spine density on layer II/III pyramidal neurons after MD [309]. However,
studies focusing on MMP-3 in visual cortex plasticity are lacking. Here we
investigated the role of this specific endopeptidase in ME-induced plasticity of
the visual cortex using adult MMP-3 deficient (MMP-3-/-) mice. An assessment
of MMP-3 deficiency on the structure and functionality of the adult visual
cortex is crucial to understand plasticity-related manipulations in these mice.
Here, we describe a phenotypical characterization of the visual cortex of MMP-
3-/- mice using Golgi-cox staining, revealing an aberrant neuronal morphology.
Western analysis of cytoskeletal proteins disclosed a di erential composition of
neurofilament proteins complementing these findings. Finally, to assess these
impairments at a functional level we performed ME to probe for an involvement
of MMP-3 in experience-dependent cortical plasticity.
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2.2 Material and methods
2.2.1 Animals
All experiments were performed in adult (120 days old) wildtype (WT) and
MMP-3 deficient (MMP-3-/-) mice with a similar genetic background (50%
Bl6 x 25% B10 x 25% RIII) (Mudgett, Merck Labs) which were housed under
standard laboratory conditions under an 11/13h dark/light cycle with food and
water available ad libitum. All experiments have been approved by the Ethical
Committee of the university and were in strict accordance with the European
Communities Council Directive of 22 September 2010 (2010/63/EU) and with
the Belgian legislation (KB of 29 May 2013). Every possible e ort was made to
minimize animal su ering and to reduce the number of animals.
2.2.2 Golgi-cox staining
WT (n = 3) and MMP-3-/- (n = 3) mice received an intraperitoneal injection of
sodium pentobarbital (Nembutal, 600 mg/kg, Ceva Sante Animale) before being
perfused transcardially with 1% paraformaldehyde (PFA, Sigma-Aldrich, St.
Louis, MO) in 0.15M phosphate-bu ered saline (PBS, pH 7.42) at 37 ¶C. Brains
were dissected and post-fixated in 4% PFA in PBS for 1 hour after which they
were impregnated with the Golgi staining solution (FD Rapid GolgiStain kit,
FD Neurotechnologies Inc., USA) for 12 to 14 days in complete darkness. The
impregnated brains were further processed using a vibratome (Leica VT1000S,
Leica Microsystems GmbH, Wetzlar, Germany) into 80 µm-thick coronal sections.
These sections were stained in developing solution (FD Rapid GolgiStain Kit),
placed on glass slides and air dried for three days before being dehydrated and
coverslipped for imaging with bright field microscopy (Zeiss Axio Imager Z.1,
software program Axiovision Rel. 4.6, Carl Zeiss Benelux).
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2.2.3 Morphometric quantification
The dendritic composition of layer V pyramidal cells (n = 12-15 / animal)
exhibiting complete Golgi impregnation, was manually traced on flattened Z-
stack images using the brush tool in Adobe Photoshop CS5 and a pen tablet
(Wacom Co., Ltd.). To exclude possible misinterpretations of branching patterns,
the tracings done on the flattened images were checked against the original
Z-stack data. For each extracted neuron the apical shaft length, mean oblique
length, number of obliques, number of branching points and spine density on
the apical shaft were measured using Axiovision Rel. 4.6 (Carl Zeiss, Benelux).
The spine density was determined at a final magnification of x1000 by manually
counting the spines on two consecutive 25 µm segments on the apical shaft
of each neuron starting at a distance of 50 µm away from the cell body. The
dendritic diameter was noted every 25 µm. For each segment the length of
up to ten spines was measured and only spines with a clear connection to the
apical shaft were included. For each condition, the data was presented as the
mean ± standard error of the mean (SEM).
2.2.4 Western Blotting
For each mouse (WT: n = 6, MMP-3-/-: n = 6) the visual cortex was collected
from 100 µm-thick coronal cryosections spanning Bregma levels -2.00 to -4.60.
Proteins were extracted with a lysis bu er (50 mM Tris, 5 mM EDTA, 1% Triton
X-100, 1 mM DTT, pH 7.4 and complete protease inhibitor cocktail (Roche
Diagnostics Ltd, Mannheim, Germany)) and the samples were centrifuged (8000
x g) for 5 minutes at 4 ¶C. The supernatant was isolated and the total protein
concentration was determined by means of a QubitTM fluorometer (Invitrogen,
Merelbeke, Belgium). Samples were stored at -80 ¶C. For immunodetection of
non-phosphorylated neurofilament-high (NF-H), phosphorylated neurofilament-
high/-medium (pNF-H/-M), neurofilament-low (NF-L) and –-internexin (NF-
66), equal amounts of protein (10 µg) were loaded onto 4-12% Bis-Tris Midi
gels (NuPAGE Novex, Invitrogen) and transferred to a polyvinylidene fluoride
(PVDF) (NF-L) or nitrocellulose (NF-H, pNF-H/M and NF-66) membrane.
The choice of membrane was empirically determined based on signal-to-noise
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ratio. Overnight incubation with the monoclonal antibody SMI-32R (anti-
NF-H, 1:500, Covance Research Products, USA; Sternberger and Sternberger
1983), SMI-31R (anti-pNF-H/pNF-M, 1:1000, Covance Research Products,
USA; Sternberger and Sternberger 1983), anti-NF-L (1:5000, Mab1615, Merck
Millipore, Germany) and anti-NF-66 (1:5000, NBP1-49175, Novus Biologicals,
USA) was followed by 30 minutes incubation with HRP-labeled secondary
antibodies (1:50000, Dako, Denmark). The immunoreactive bands were
visualized using a luminol-based enhanced chemiluminescent kit (SuperSignal
West Dura, Thermo Scientific, USA). In order to correct for inter-gel variability
and to normalize the concentration of the specific detected proteins to the
total amount of protein present, we performed a total protein stain (TPS)
prior to immunodetection with LavaPurple (Gelcompany, USA) according to
manufacturer’s instructions. After the staining, dry blots were scanned with a
ChemiDocTM MP Imaging System (Bio-Rad Laboratories, USA). The protein
bands were semi-quantitatively evaluated by densitometry (Image Lab 4.1,
Bio-Rad Laboratories, USA). First, to account for inter-gel variability including
loading di erences, incomplete transfer or position on the blot, a TPS was
employed rather than the use of a single reference protein [6, 146]. For each
protein of interest, the optical density value per mouse was normalized to its
corresponding TPS. Also, to compare samples between di erent gels, normalized
data were expressed relative to the reference sample, i.e. a pool of all samples.
2.2.5 Monocular enucleation and in situ hybridization
Monocular enucleation of the mice (n = 4 / condition) was performed as
previously described [2, 256, 333]. Briefly, under anesthesia by intraperitoneal
injection of a mixture of ketamine hydrochloride (75 mg/kg, Dechra Veterinary
Products, Eurovet) and medetomidine hydrochloride (1 mg/kg, Orion
Corporation, Janssen Animal Health), the right eye was carefully removed
and if needed, the orbit was filled with hemostatic cotton wool (Qualiphar,
Bornem, Belgium). After injection with atipamezol hydrochloride (1 mg/kg,
Orion Corporation, Elanco Animal Health) to reverse anesthesia, the animals
were allowed to recover on a heating pad. They were all administered 0.05 ml
of antibiotics (Kefzol, 1 g Natrii cefazolin and 15 mg Lidocaini hydrochloridum
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anhydricum in 4 ml 0.9% NaCl, Eurocept Pharmaceuticals) intramuscularly to
prevent post-surgical infections. After the enucleation procedure, mice were
again housed under the same normal light conditions in standard cages for a
survival period of seven weeks. Prior to sacrifice, the animals underwent an
overnight dark-exposure followed by 45 min of bright light to obtain an optimal
visually evoked zif268 expression [367, 161, 9, 387, 336]. For in situ hybridization
experiments, all mice received an overdose of sodium pentobarbital (Nembutal,
600 mg/kg, Ceva Sante Animale) by intraperitoneal injection prior to sacrifice
by cervical dislocation. The brains were rapidly removed and immediately frozen
in 2-methylbutane (Merck, Overijse, Belgium) at a temperature of -40 ¶C and
stored at -80 ¶C until sectioning. Twenty-five µm-thick sections were prepared
on a cryostat (Microm HM 500 OM, Walldorf, Germany), mounted on 0.1%
poly-L-lysine (Sigma–Aldrich, St. Louis, MO)-coated slides and stored at -20
¶C until further processing.
In situ hybridization was performed with a mouse-specific synthetic oligonu-
cleotide probe (Eurogentec, Seraing, Belgium) with sequence 5’-ccgttgctcagc-
agcatcatctcctccagtttggggtagttgtcc-3’ for zif268. This oligonucleotide probe has
been used successfully for the analysis of zif268 mRNA expression in the mouse
brain in previous publications [334, 366, 256]. As described earlier [10, 55],
each probe was 3’-end labeled with 33P-dATP using terminal deoxynucleotidyl
transferase (Invitrogen, Paisley, UK). Unincorporated nucleotides were separated
from the labeled probe with miniQuick SpinTM Oligo Columns (Roche
Diagnostics, Brussels, Belgium). Series of cryostat sections (every 50 µm)
were fixed, dehydrated and delipidated. The radioactively labeled probe was
added to a hybridization cocktail (50% (vol/vol) formamide, 4x standard saline
sodium citrate bu er, 1 x Denhardt’s solution, 10% (wt/vol) dextran sulphate,
100 µg/ml herring sperm DNA, 250 µg/ml tRNA, 60 mM dithiothreitol, 1%
(wt/vol) N-lauroyl sarcosine, 20 mM NaHPO4, pH 7.4) and applied to the
cryostat sections (106 cpm per section) for an overnight incubation at 37 ¶C in
a humid chamber. The following day, sections were rinsed in 1x standard saline
sodium citrate bu er at a temperature of 42 ¶C, dehydrated, air-dried and
exposed to an autoradiographic film (Biomax MR, Kodak, Zaventem, Belgium).
Films were developed in Kodak D19 developing solution after 7 days and
fixation was performed in Rapid fixer (Ilford Hypam, Kodak). For each mouse,
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autoradiographic images from three adjacent sections were scanned at 1200
dpi (CanoScan LIDE 600F, Canon, USA). Pseudo-color maps were generated
with a custom-made MATLAB script (MATLAB R2008b, The MathWorks Inc.,
Natick, MA) and represent a false coloring of the gray values: a low gray value
is represented in black/green, a high gray value in white/yellow, indicating
a low signal response or a high signal response respectively. This is done in
accordance with a gray scale ranging from black (0) to white (255).
2.2.6 Histology
Histology was performed on each section to aid interpretation of the activity
patterns obtained by in situ hybridization. The cryostat sections for zif268 were
therefore Nissl-counterstained (Cresyl violet 1%, Fluka Chemika, Sigma-Aldrich)
according to standard procedures. Comparisons were made to a stereotaxic
mouse brain atlas [110]. Images of the stained coronal sections were obtained
with a light microscope (Zeiss Axio Imager Z.1) equipped with an AxioCam
MRm camera (1388x1040 pixels) using the software program Axiovision Rel.
4.6 (Carl Zeiss Benelux).
2.2.7 Localization of visual areal boundaries with Nissl patterns
To anatomically delineate the areal borders of the di erent visual subdivisions a
comparison was made with Nissl counterstained sections as described previously
by Van Brussel et al. (2009; 2011) and Nys et al. (2014) [333, 334, 256]. All
topographic denominations were adopted from these papers. Concurrently, we
applied the mapping of functional subdivisions of the visual cortex as located
by Van Brussel et al. (2009) where the eye-specific inputs were identified
using enucleation of one eye combined with stimulation of the remaining
eye. Combined, these methods allowed for the generation of animal specific
coronal atlases of the visual cortex and thus provided a reliable guide for
the interpretation of zif268 in situ hybridization results. In all figures, large
arrowheads indicate the total extent of the visual cortex while small arrowheads
indicate areal borders. We always distinguished five regions from medial to
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lateral: medial extrastriate cortex (V2M), primary visual cortex (V1), which
was further subdivided in the monocular (V1m) and the binocular (V1b) part
and lateral extrastriate cortex (V2L), which was also subdivided in a monocular
(V2Lm) and a binocular (V2Lb) region. In relation to functional inputs, we
defined the V1–V2L border as the central binocular zone (Bz), a large part of
V2M and V1m as the medial monocular zone (Mmz), and V2Lm as the lateral
monocular zone (Lmz). In figures 4 and 5, the location of the binocular zone
has been indicated with the gray letter b. Adjoining monocularly driven parts
of V1 and V2L are marked with a gray letter m.
2.2.8 Quantitative analysis of ISH results
As described before [256], optical density values (mean gray value per pixel) from
the autoradiograms of di erent experimental and control groups were quantified
using a custom-made MATLAB script (MATLAB R2008b, The MathWorks
Inc., Natick, MA). For each condition at least 3 mice were included and for each
mouse three 25 µm-thick sections were selected between -3.00 mm and -4.00 mm
relative to Bregma [110]. In order to demarcate the region of interest in the left
hemisphere, we determined the top edge of the cortex, the border between the
granular layer IV and infragranular layer V and the boundary where layer VI
meets the white matter. These layer-related borders were computed by a contour
smoothing algorithm based on the Gaussian weighted least squares fit [27] from
manually drawn lines on the autoradiogram. The di erent areal and functional
boundaries as derived from Nissl patterns were subsequently registered to the
curvature of the top and bottom boundaries. Next, the delineated region of
interest was equally divided into 24 segments [62] creating two lattices of 24
quadrangles, corresponding to the upper (LII-IV) and lower (LV-VI) layers. To
compensate for possible variation in brain size and morphology, we translated
the lattice on each autoradiogram over the cortical curvature, fixing the border
of a specific segment to an areal border (border segment 19/20 is area border
V1m/V2M). For each segment created this way, the relative optical density was
calculated as the mean gray value of all pixels within this quadrangle normalized
to the mean gray value of a square measured in the thalamus (a defined region
with no zif268 expression above background). This procedure was required
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to compare autoradiograms across experiments [270, 334]. Relative molecular
activity was expressed in percentages based on the following formula: (1 -
(cortical zif268/thalamic background)) x 100. We compared zif268 expression
between di erent experimental and control groups for upper and lower layers
of the visual cortex separately. Furthermore, relative expression patterns were
assessed along the anatomically defined visual subdivisions as well as in the
functionally distinct areas consisting of the central binocular zone and two
flanking monocular zones.
2.2.9 Statistics
All Western blot data and data of the Golgi-cox staining except for the spine
length distribution, were presented as mean ± SEM. A normal distribution was
verified using the Kolmogorov–Smirnov test and parallel equal variance between
groups was tested. If the test requirements were fulfilled, an unpaired Student’s
t-test for pairwise comparison was used (*P < 0.05, **P < 0.01, ***P < 0.001).
When criteria for this parametrical test were not fulfilled, a Mann-Whitney
U rank sum test for pairwise comparison of independent samples was applied
(*P < 0.05, **P < 0.01, ***P < 0.001). For comparing the distribution of
spine length across groups, a chi-square analysis was performed and data was
presented as the percentage of total spine number per spine length interval.
To compare the ISH results for each condition, the data of relative optical
densities was presented as mean ± SEM. A normal distribution was verified
using the Kolmogorov–Smirnov test and parallel equal variance between groups
was tested. If the test requirements were fulfilled, for the ISH data a two-way
ANOVA was used with factors zone (functional: binocular, medial monocular
or lateral monocular zone) and genotype (WT or MMP-3-/-) or deprivation
(control of 7wME) to test for ME-specific changes in zif268 expression. Fisher’s
LSD post hoc tests were used for pairwise comparisons and a probability level
of < 0.05 (–-level was set to 0.05) was accepted as statistically significant (*P <
0.05, **P < 0.01, ***P < 0.001). When criteria for this parametrical test were
not fulfilled, a non-parametrical Kruskal-Wallis analysis with a Mann-Whitney
U rank sum test for pairwise comparison of independent samples was applied.
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When no interaction between the two factors studied was observed a one-way
ANOVA with an unpaired Student t-test for pairwise comparison was used (*P
< 0.05, **P < 0.01, ***P < 0.001). Statistical analyses were performed using
SigmaStat 3.1 (SYSTAT software).
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2.3 Results
2.3.1 Truncated neuronal morphology and impaired translam-
inar projections in the visual cortex of MMP-3 deficient
mice
Golgi-Cox staining revealed normal vertical projections across all cortical layers
in V1 of WT mice. In contrast, MMP-3-/- mice displayed an apparent, truncated
translaminar organization (figure 2.1a-b). To address this anatomical feature
in more detail, we analyzed layer-specific pyramidal neurons, since they are
typically characterized by long apical dendrites supporting the vertical oriented
appearance of the stained cortex. Layer V pyramidal cells of MMP-3-/- mice
displayed a significant reduction (P < 0.001) in the length of the apical shaft
(figure 2.2a-c) and a comparable number of apical branches called obliques (P
= 0.666), together resulting in a higher density of apical obliques (# apical
obliques/ apical shaft length, P < 0.001) compared with WT mice (figure
2.2d-e). No di erences between the two genotypes concerning mean oblique
length (P = 0.490) or branching complexity (mean # branch points per neuron,
P = 0.298) were observed (figure 2.2f-g). These measurements indicate that
MMP-3-/- mice have a shorter apical shaft with more apical obliques per unit
of length. Spine density on the apical shaft was the same in both genotypes (P
= 0.893) whereas the distribution of spine length showed significantly shorter
spines (chi-square = 10.701, df = 3, P = 0.013) in MMP-3-/- mice compared
with WT (figure 2.2h-j). These results indicate a higher prevalence of shorter,
more mature spines in the cortex of MMP-3-/- mice. No di erences in soma
size were observed. Dendritic diameter did not di er in each measured segment
so no correction factor for spine density was employed [153].
2.3.2 Cytoskeletal protein anomalies in the visual cortex as a
result of MMP-3 deficiency
To corroborate the truncated neuronal morphology in the MMP-3-/- mice on a
molecular level, we compared the expression levels of di erent neurofilament
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Figure 2.1: Representative bright field images of Golgi-Cox stained primary visual
cortex of WT (a) and MMP-3-/- (b) mice.
A perturbed translaminar organization characterizes the visual cortex of MMP-3-/-
mice. Scale bars: 150 µm.
protein subunits in cortices of both genotypes using Western analysis since they
constitute the major components of the neuronal cytoskeleton. All analyzed
neurofilament protein subunits were found to be significantly upregulated in the
visual cortex of MMP-3-/- mice (figure 2.3a-e: non-phosphorylated neurofilament-
high (NF-H), P = 0.026, ratio = 1.9; phosphorylated neurofilament-high (pNF-
H), P = 0.011, ratio = 2.2; phosphorylated neurofilament-medium (pNF-M),
P = 0.002, ratio = 3.0; neurofilament-low (NF-L), P < 0.001, ratio = 5.9 and
–-internexin (NF-66), P < 0.001, ratio = 2.3). These results are indicative
for an altered neurofilament protein subunit composition and phosphorylation
state.
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Figure 2.2: Morphological analysis of layer V pyramidal neurons in the visual cortex
of WT and MMP-3-/- mice.
a-b) Representative traced pyramidal neurons of WT and MMP-3-/- mice. Scale
bars: 20 µm. Morphometric evaluation of the apical shaft length (c), absolute
number of obliques (d), relative number of obliques (e), mean oblique length (f) and
number of apical branch points (g) evidence a significant shorter apical dendrite and
higher density of apical obliques in MMP-3-/- mice. Values in c-g represent mean ±
SEM. Student’s t-test: *** P < 0.001 (c) and Mann-Whitney-U test *** P < 0.001
(e). h) Representative Golgi-cox stained dendritic spines on the apical shaft. Final
magnification: 1000x. Scale bars: 5 µm. i) Dendritic spine density is not altered by
MMP-3 deficiency. j) Frequency distribution of dendritic spine length measured from
50-100 µm from the soma indicate a higher abundance of shorter spines in MMP-3-/-
mice (Chi-square = 10.701, df = 3, P = 0.013).
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Figure 2.3: Analysis of di erent neurofilament protein subunit levels in the visual
cortex of WT and MMP-3-/- mice.
All analyzed neurofilament protein subunits are significantly upregulated in
MMP-3-/- mice: (a) non-phosphorylated neurofilament-high (NF-H), P = 0.026;
(b) phosphorylated neurofilament-high (pNF-H), P = 0.011; (c) phosphorylated
neurofilament-medium (pNF-M), P = 0.002; (d) neurofilament-low (NF-L), P <
0.001 (e) and –-internexin (NF-66), P < 0.001 with *P < 0.05, **P < 0.01, ***P
< 0.001. Above each graph representative bands and their corresponding molecular
weight are shown. Values in a-e represent mean ± SEM.
2.3.3 An aberrant visual and cross-modal response to mono-
cular enucleation in MMP-3 deficient mice
In order to assess the response of the visual cortex to ME as a plasticity readout,
we performed radioactive in situ hybridization (ISH) for the activity marker
gene zif286, as a reliable reporter for light-induced neural activity [333, 334, 256].
ME is a useful model to investigate not only open-eye potentiation (unimodal)
but also the cross-modal component of visual cortical plasticity in the mouse
[334, 256]. Here we applied the same deprivation protocol to WT and MMP-3-/-
mice to assess the functional outcome of ME in the context of the drastically
altered neuronal architecture in MMP-3-/- mice. To exclude possible intrinsic
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e ects of MMP-3 deficiency on visually evoked zif268 expression, we compared
the activity profiles of WT control and MMP-3-/- control mice. No significant
di erences were found between these two conditions (figure 2.4), suggesting
MMP-3 deficiency itself has no apparent e ect on zif268 expression in the
visual cortex. Furthermore, it is known that variation in the genetic background
a ects the capacity for ocular dominance (OD) plasticity in mice [135] and
normal adult C57Bl/6J mice display an extensive reactivation along the full
extent of the visual cortex within seven weeks of ME. Hence, we tested whether
the genetic background of the WT mice influenced the reactivation pattern
seven weeks post-ME by comparing age-matched WT mice versus seven weeks
enucleated littermates (figure 2.5a-b). Only the infragranular layers of the medial
monocular zone (Mmz: V1m and V2M) of the enucleated mice (WT 7wME)
showed a significant reduction (figure 2.5d Mmz: P = 0.009; figure 2.5c Mmz:
P = 0.057) in zif268 expression compared to the age-matched controls (WT
control). Yet the binocular zone (Bz: V1b and V2Lb) and lateral monocular
visual cortex (Lmz: V2Lm) exhibited no di erence in zif268 expression between
conditions (figure 2.5c, Bz: P = 0.715, Lmz: P = 0.523; figure 2.5d, Bz: P
= 0.495, Lmz: P = 0.886). These results are very comparable to previous
observations in C57Bl/6J mice [334, 256], ruling out a clear e ect of the WT
genetic background on ME-induced cortical plasticity.
Next, the zif268 expression in the visual cortex of WT 7wME was compared to
that of MMP-3-/- 7wME to primarily determine the e ect of MMP-3 deficiency
on cross-modal plasticity (figure 2.6a-b). A massive decrease in zif268 expression
in the two monocular zones across all layers (figure 2.6c, Lmz: P = 0.012; Mmz:
P < 0.001; figure 2.6d, Lmz: P = 0.003; Mmz: P < 0.001) was observed in
MMP-3-/- 7wME mice compared to WT 7wME. The hypoactivity in response
to ME was mostly located in monocular driven areas since the relative neural
activity remained confined to the Bz (figure 2.6b). The zif268 expression in the
Bz was only significantly di erent in the infragranular layers (figure 2.6d, Bz: P
= 0.007) and not in the supragranular layers (figure 2.6c, Bz: P = 0.072). Taken
together, these results indicate perturbed cross-modal plasticity and open-eye
potentiation in the visual cortex of adult MMP-3-/- mice.
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Figure 2.4: Zif268 expression in the visual cortex of WT and MMP-3-/- mice reveals
no significant di erences.
For both conditions images of the left visual cortex from three adjacent sections around
Bregma level -3.40 mm are shown. The corresponding pseudo-color representations of
signal intensity di erences are displayed next to each triplet of ISH sections. The medio-
lateral extent of the visual cortex is marked by the two large arrowheads and interareal
boundaries with smaller arrowheads, as identified in the histologically processed
slices (Nissl, see methods). Line graphs (c,d) illustrate the relative zif268 expression
for the upper (LII-LIV) (c) and lower (LV-VI) (d) layers along the five predefined
visual subdivisions (black arrowheads, corresponding with the small arrowheads in
the images of a and b as measured by the average optical density in each segment,
using a custom-made MATLAB script, for WT controls (black lines) and MMP-3-/-
controls (gray lines) animals. No significant di erences between the subregion-specific
activity profiles of WT and MMP-3-/- control levels were found which indicates that
MMP-3 deficiency has no overt e ects on normal zif268 expression levels. Error
bars represent the SEM of the mean optical density in each segment. Abbreviations:
A, anterior; P, posterior; M, medial; L, lateral; V2M, medial extrastriate cortex;
V1m, monocular primary visual cortex; V1b, binocular primary visual cortex; V2Lb,
binocular lateral extrastriate cortex; V2Lm, monocular lateral extrastriate cortex;
Lmz, lateral monocular zone; Bz, binocular zone; Mmz, medial monocular zone; m,
monocular; b, binocular; ME, monocular enucleation; w, weeks. Scale bars: 2 mm.
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Figure 2.5: Zif268 expression in the visual cortex of WT control (a) and WT mice
enucleated for seven weeks (b) reveals di erent reactivation patterns.
For both conditions images of the left visual cortex from three adjacent sections around
Bregma level -3.40 mm are shown. The corresponding pseudo-color representations of
signal intensity di erences are displayed next to each triplet of ISH sections. The medio-
lateral extent of the visual cortex is marked by the two large arrowheads and interareal
boundaries with smaller arrowheads, as identified in the histologically processed
slices (Nissl, see methods). Line graphs (c,d) illustrate the relative zif268 expression
for the upper (LII-LIV) (c) and lower (LV-VI) (d) layers along the five predefined
visual subdivisions (black arrowheads, corresponding with the small arrowheads in
the images of a and b as measured by the average optical density in each segment,
using a custom-made MATLAB script, for controls (black lines) and 7wME (gray
lines) animals. In WT 7wME the subregion-specific activity profiles do not di er from
WT control levels except for the medial monocular zone in the infragranular layer,
interpreted as evidence for visual and cross-modal reactivation. Error bars represent
the SEM of the mean optical density in each segment. Statistics with *P < 0.05,
**P < 0.01, ***P < 0.001. Abbreviations: A, anterior; P, posterior; M, medial; L,
lateral; V2M, medial extrastriate cortex; V1m, monocular primary visual cortex; V1b,
binocular primary visual cortex; V2Lb, binocular lateral extrastriate cortex; V2Lm,
monocular lateral extrastriate cortex; Lmz, lateral monocular zone; Bz, binocular
zone; Mmz, medial monocular zone; m, monocular; b, binocular; ME, monocular
enucleation; w, weeks. Scale bars: 2 mm.
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Figure 2.6: Zif268 expression in the visual cortex of WT (a) and MMP-3-/- (b) mice
seven weeks post-enucleation reveals di erent reactivation patterns.
For both conditions images of the left visual cortex from three adjacent sections around
Bregma level -3.40 mm are shown. The corresponding pseudo-color representations
of signal intensity di erences are displayed next to each triplet of ISH sections. The
medio-lateral extent of the visual cortex is marked by the two large arrowheads
and interareal boundaries with smaller arrowheads, as identified in the histologically
processed slices (Nissl, see methods). Line graphs (c,d) illustrate the relative zif268
expression for the upper (LII-LIV, c) and lower (LV-VI, d) layers along the predefined
visual subdivisions (black arrowheads, corresponding with the small arrowheads in the
images of a and b) as measured by the average optical density in each segment, using a
custom-made MATLAB script, for WT (black lines) and MMP-3-/- (gray lines) animals.
A lack of cross-modal plasticity in MMP-3-/- mice seven weeks post-enucleation is
clearly visible as evidenced by the remarkable decrease in zif268 expression in all
monocular driven areas. Open-eye potentiation in these animals seems perturbed
since the zif268 pattern does not expand into V1m and V2Lm. Error bars represent
the SEM of the mean optical density in each segment. Statistics with *P < 0.05,
**P < 0.01, ***P < 0.001. Abbreviations: A, anterior; P, posterior; M, medial; L,
lateral; V2M, medial extrastriate cortex; V1m, monocular primary visual cortex; V1b,
binocular primary visual cortex; V2Lb, binocular lateral extrastriate cortex; V2Lm,
monocular lateral extrastriate cortex; Lmz, lateral monocular zone; Bz, binocular
zone; Mmz, medial monocular zone; m, monocular; b, binocular; ME, monocular
enucleation; w, weeks. Scale bars: 2 mm.
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2.4 Discussion
2.4.1 Linking MMPs to dendrite arborization
Within this study we demonstrate that genetic inactivation of MMP-3 has
profound e ects on the structural and functional integrity of the visual cortex
in adult mice. In fact, images of Golgi-Cox-stained cortices could be assigned to
either originating from WT or MMP-3-/- mice, based on structural appearance.
In more detail, layer V pyramidal cells of MMP-3-/- mice displayed significantly
shorter apical dendrites and more apical obliques per unit of length, providing
one explanation for the truncated translaminar appearance of the Golgi-Cox-
stained MMP-3-/- cortex. Consistent with our results, recent work by Van Hove
et al. (2011) showed a reduced dendritic tree size of cerebellar Purkinje cells
in MMP-3-/- mice compared with WT, both at P12 and P90 [339]. This study
clearly revealed that genetic inactivation of MMP-3 has profound e ects on
brain development with a neuronal phenotype that persists into adulthood.
The exact mechanism by which MMP-3 mediates the abnormal dendritic
arborization remains elusive but MMP-dependent activation of neurotrophins
provides an attractive mechanism. Several neurotrophins and growth factors
such as insulin-like growth factor-1 (IGF-1) are known to not only influence
dendritic outgrowth but also to play a role in visual cortex plasticity
[213, 251, 197, 212]. They might therefore be suggested as putative MMP-3
targets mediating the observed phenotype. All known mammalian neurotrophins
act as major regulatory signals in the lamina-specific development of apical and
basal dendrites in the visual cortex of the mouse [213]. Specifically, brain-derived
neurotrophic factor (BDNF), a known substrate of MMP-3 [188, 227] regulates
the growth and branching of layer V pyramidal cells in the visual cortex [213].
Nerve growth factor has similar e ects as BDNF on dendritic arborization and
regulates MMP-3 expression [255] and can be activated by MMP-7 [188], itself
an in vitro substrate of MMP-3 [214].
Other alternative mechanisms might involve MMP mediated integrin [303] and
semaphorin signaling [123]. Several MMPs can be linked to integrin-mediated
signaling pathways by interaction with ECM molecules [303, 356, 223] and
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genetic ablation of integrin-mediated signaling results in post-developmental,
progressive retraction of dendritic arbors of layer V pyramidal neurons in
the somatosensory and visual cortex of the mouse [233, 225]. On the other
hand, a functional link between MMPs and guidance molecules, including
semaphorins has previously been established [215]. Specifically, MMP-3 is
required for semaphorin-3C-dependent cortical axon outgrowth and is negatively
regulated by the axonal growth inhibitory semaphorin-3A [123]. Besides having
e ect on axons, class 3 semaphorins regulate dendritic growth and branching
[249, 104, 157]. Alternatively, MMP-3 may be implicated in sculpting dendritic
architecture by regulating the bio-availability of IGF-1 through selective cleavage
of IGF-binding protein-3 [109, 227] and IGF-1 is crucial for apical dendritic
growth in layer II pyramidal neurons [251].
2.4.2 MMPs regulate dendritic spine development and dyna-
mics
It has been previously established that MMPs are expressed in dendritic spines
[180] and are necessary for dendritic spine maturation and actin dynamics by
phosphorylation of cofilin through —1-integrin-dependent signaling [80, 356, 56]
or by directly cleaving the actin filament-severing protein gelsolin and other
cytoskeletal proteins [40, 347]. Indeed, we observed a significant shift in dendritic
spine length distribution towards shorter spines in MMP-3-/- mice, indicating a
role for this metalloproteinase in spinogenesis and spine maturation. Earlier
studies on dendritic spines and MMPs revealed that inhibition of MMPs by
minocycline induces spine maturation in cultured hippocampal neurons [25]
while in contrast, elevated activity of MMP-7 and MMP-9 increases spine
length both in vitro and in vivo respectively [224, 26, 97]. Since MMP-9 can
be activated by MMP-3 [258, 214] and MMP-3-/- mice are characterized by a
reduced proMMP-9 activation in vivo [160], it is conceivable that a reduced
MMP-9 activity is responsible for the observed shift in spine length distribution
towards shorter, more mature spines. Whether MMP-3 is an e cient activator
of MMP-7 in vivo is still a matter of debate [285], making it more di cult
to attribute the observed dendritic spine phenotype to a reduced activity
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of MMP-7. Also, a recent study by Spolidoro et al. (2012) demonstrated
that MMP inhibition prevented the increase in immature spines in the visual
cortex of juvenile rats after seven days of monocular deprivation (MD) [309],
substantiating MMP-mediated structural plasticity in the visual system.
2.4.3 Neurofilament protein upregulation
The observed aberrant dendritic morphology of MMP-3-/- pyramidal neurons is
indicative for abnormal cytoskeletal dynamics. Hence, we wanted to discern
the contribution of neurofilament proteins (NF) to this phenotype since they
constitute the major components of the neuronal cytoskeleton. Surprisingly,
when comparing the NF content in the visual cortex of WT and MMP-3-/-
mice, we found a significant upregulation in MMP-3-/- mice for –-internexin
(NF-66) and the light (NF-L), medium (NF-M) and heavy (NF-H) subunits,
both phosphorylated (p) and non-phosphorylated. All analyzed subunits
displayed a di erent degree of upregulation, ranging from 1.9-fold (NF-H)
to 5.9-fold (NF-L), suggesting an overall change in NF subunit stoichiometry in
MMP-3-/- mice. A normal NF subunit stoichiometry is essential for proper NF
assembly and transport and alterations in stoichiometry have been implicated
in several neurodegenerative diseases [159, 174, 316, 184, 15]. Kong et al. (1998)
revealed that by transgenic overexpression of di erent neurofilament subunits, an
increased ratio of NF-H and/or NF-M to NF-L inhibited dendritic arborization
in spinal motor neurons. An imbalance in the ratio of di erent NF subunits
can alter NF assembly properties and slow down NF transport into neuronal
processes which is likely to cause structural changes in dendrites [179, 67, 15].
Additionally, increased phosophorylation of NF-H and NF-M subunits can cause
slower NF transport potentially by preventing attachment to molecular motors
[67, 63, 15].
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2.4.4 Genetic removal of MMP-3 abolishes cross-modal
plasticity and perturbs open-eye potentiation
Since the MMP family has recently been implicated in visual cortex plasticity
[309], we here probed for cross-modal plasticity in MMP-3-/- mice by means
of the long-term monocular enucleation (ME) paradigm [256, 334]. The zif268
activity profile of WT enucleated mice (WT 7wME, figure 4) revealed a nearly
full reactivation along the entire medio-lateral visual cortex thereby resembling
zif268 expression levels in WT control animals with only a slight decrease in
activity in the infragranular layer of the medial monocular zone (figure 2.5d).
These results are consistent with previous data obtained in adult C57Bl/6J
mice [256, 334] and indicate that the di erent genetic background of our WT
mice compared to C57Bl/6J has a negligible e ect on the cortical plasticity
phenomena studied here [135]. In contrast, the lack of cross-modal reactivation
in adult MMP-3-/- mice 7wME (figure 2.6) is most likely a result of the truncated
translaminar organization described above. Since pyramidal neurons in the
visual cortex are essential for intra-areal and inter-areal information processing
[311, 83, 155], the dendritic phenotype observed in MMP-3-/- likely disrupts
the intra-areal and inherently the cortico-cortical framework necessary for cross-
modal plasticity [256, 334, 268]. Besides the apparent absence of cross-modal
plasticity, open-eye potentiation seemed perturbed as well. Indeed, the zif268
pattern remained confined to the binocular zone and did not expand into the
monocular regions as expected based on previous publications [64, 165, 101, 256].
Furthermore, the permanently decreased zif268 expression in the infragranular
layer of the binocular zone also supports this interpretation of an altered open-
eye potentiation. General MMP inhibition was recently reported to selectively
prevent the potentiation of the open-eye after 7 days of MD in the visual cortex
of juvenile rats [309]. This experience-dependent potentiation is necessary for a
complete OD shift [111, 300] and ME induces robust OD plasticity driven by
the remaining eye [64, 165]. Considerable molecular data has been obtained
from classic MD experiments. In that regard, it is established that several
neurotrophins, which are substrates of MMPs, modulate the outcome of MD [197,
202, 29] where administration of NGF or BDNF disrupts OD plasticity [197].
Moreover, BDNF is critically involved in the induction of long-term potentiation
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(LTP) in dendrites and spines [182]. Although MMP-3 is necessary for activation
of these neurotrophins, genetic inactivation of MMP-3 likely induces complex
degradomic cascades [266, 38] including compensatory upregulation of other
redundant MMPs that can activate these neurotrophins [97, 95]. Furthermore,
it is known that MMP-9, a putative downstream target of MMP-3 is necessary
to maintain LTP and is upregulated by synaptic activity [360, 152, 247]. Classic
OD plasticity cannot be explained solely by homosynaptic mechanisms [139, 16].
Homeostatic plasticity has been suggested to also play a role [164, 72, 236].
Accordingly, tumor necrosis factor-– (TNF-–) deficient mice lack the open-eye
response typical for MD which has been attributed to perturbed homeostatic
synaptic scaling [164]. Pro-TNF-– is activated by several MMPs, including
MMP-3 [116, 314] so the lack of MMP-3 can therefore perturb the response
of the remaining eye possibly via TNF-–. However, general MMP-inhibition
did not alter homeostatic plasticity in the primary visual cortex of juvenile
rats following seven days of MD [309]. Taken together, it is conceivable that
lack of MMP-3 and the resulting degradome disrupts this experience-dependent
potentiation process, contributing to the observed phenotype.
2.4.5 Conclusions
Genetic inactivation of MMP-3 clearly has profound e ects on the structural
and functional integrity of the visual cortex of adult mice. MMP-3 is necessary
to constitute a normal phenotype of layer V pyramidal neurons since genetic
ablation of this enzyme severely impacts apical dendritic length, branching
and spine length. Additionally, we revealed an aberrant cortical plasticity
phenotype characterized by a perturbed open-eye potentiation and lack of cross-
modally driven reactivation. Most likely this is the result from the apparent
truncated translaminar cortical organization that disrupts the intra-areal and
cortico-cortical communication needed for experience-dependent plasticity in
combination with the perturbed set of MMP-3 substrates. To our knowledge,
this is the first study that reports NF protein upregulation in an MMP deficiency
model. Further experiments are needed to elucidate whether or not MMPs can
directly interact with NF proteins to modulate cytoskeletal dynamics and which
molecular mediators constitute the observed phenotype.
Chapter 3
Altered expression of collapsin response mediator
protein-5 and autophagosomes in the visual cortex
of MMP-3 deficient mice
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3.1 Introduction
As highlighted in the previous chapter, MMP-3 deficient (MMP-3-/-) mice
displayed a truncated neuronal architecture characterized by a reduction in
apical dendritic length and dendritic spine length of layer V pyramidal neurons in
the visual cortex (chapter 2) [3]. However, the molecular and cellular mechanisms
mediating this cortical phenotype are still unclear. A functional proteomics
approach of the visual cortex of wildtype (WT) and MMP-3-/- mice revealed
a di erential set of proteins that hinted to an altered expression of collapsin
response mediator proteins (CRMPs) and proteins related to mitochondrial
dynamics (appendix figure A.1 and table A.1). To investigate this, we focused
on the analysis of all known CRMPs with a special attention to CRMP-5
which recently has been implicated in regulating mitochondrial function through
mitophagy [35]. In addition, we examined mitochondrial fusion and fission
proteins conveyed by the proteomics study.
Besides the generation of ATP, mitochondria are involved in reactive oxygen
species (ROS) metabolism, calcium signaling and apoptosis [49]. They are
mainly located in and transported to axons and the dendritic shaft and are
associated with dendritic spines during development and plasticity [192, 43,
280, 49, 201]. Mitochondria maintain their health by continuously undergoing
fission and fusion [74, 201]. Two key proteins, dynamin-related protein 1 (Drp1)
and fission protein 1 (Fis1) mediate mitochondrial fission, whereas mitofusins
(Mfn-1 and Mfn-2) and Optic Atrophy-1 (OPA-1) mediate mitochondrial fusion
[74]. Many processes, including dendritic growth and branching, spinogenesis
and neuroplasticity depend on proper mitochondrial dynamics and function
[192, 49, 35].
CRMPs (for alternative names see appendix table A.2) are a family of five
cytosolic phosphoproteins that were orginally identified as intracellular mediators
of semaphorin signaling [44, 301]. However, recent evidence shows that CRMPs
are involved in multiple cellular events, including microtubule polymerization,
actin bundling and endocytosis leading to dendritic/axonal growth and neuronal
di erentiation [36, 11, 372, 364]. All CRMPs are highly expressed during
development and their expression is downregulated in adulthood [44]. However,
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in the cortex of adult mice CRMP-1, CRMP-2B and CRMP-5 are still detectable
in the dendrite and soma of pyramidal neurons [32]. CRMP-5 has been
specifically implicated in the regulation of dendritic outgrowth by modulating
the growth promoting function of CRMP-2 [36]. CRMP-5 can be localized to
dendritic mitochondria to induce mitophagy, linking CRMPs to mitochondrial
dynamics [35]. Mitophagy or the degradation of mitochondria, is initiated
through sequestering mitochondria in spherical membrane structures called
autophagosomes. Autophagosomes in turn fuse with lysosomes to continue the
degradation process. Formation of autophagosomes is regulated by microtubule-
associated protein 1 light chain 3 (LC3) [322, 70, 388] and conversion of cytosolic
LC3-I to phosphatidylethanolamine-conjugated LC3-II is indicative for the early
formation of autophagosomes since LC3-II inserts into the autophagosome
membrane [322, 35].
In this study we revealed a significant upregulation of CRMP-5 in the visual
cortex of MMP-3-/- mice compared with WT using Western analysis, whereas the
expression levels of other CRMPs (1-4) did not di er. CRMP-5 immunoreactivity
was mainly localized in the soma and apical dendrites in in layer II/III and
V of the visual cortex, both in MMP-3-/- and WT mice. In addition, a
significant upregulation of LC3-II was observed in MMP-3-/- mice suggesting an
accumulation of autophagosomes. Finally, no di erences were detected in the
expression levels of mitochondrial fusion and fission proteins Mfn-2 and Drp1
between both conditions, suggesting that a normal mitochondrial fusion and
fission balance is present in MMP-3-/- mice.
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3.2 Material and methods
3.2.1 Animals
All experiments were performed in adult (120 days old) MMP-3 wildtype (WT)
and deficient (MMP-3-/-) mice with a similar genetic background (50% Bl6
x 25% B10 x 25% RIII) (Mudgett, Merck Labs) which were housed under
standard laboratory conditions under an 11/13h dark/light cycle with food and
water available ad libitum. All experiments have been approved by the Ethical
Committee of the university and were in strict accordance with the European
Communities Council Directive of 22 September 2010 (2010/63/EU) and with
the Belgian legislation (KB of 29 May 2013). Every possible e ort was made to
minimize animal su ering and to reduce the number of animals.
3.2.2 Western Blotting
For each mouse (WT: n = 6, MMP-3-/-: n = 6) the visual cortex was collected
from 100 µm-thick coronal cryosections spanning Bregma levels -2.00 to -4.60.
Proteins were extracted with a lysis bu er (CRMPs: 7M urea, 2M thiourea,
4% CHAPS, 1% DTT, 40 mM Tris, and complete protease inhibitor cocktail
(Roche Diagnostics Ltd, Mannheim, Germany); LC3-II, Mfn-2 and Drp1: RIPA
bu er). and the samples were sonicated and heated for 5 minutes at 70 ¶C.
Next, the samples were centrifuged (10000 x g) for 5 minutes at 4 ¶C. The
supernatant was isolated and the total protein concentration was determined by
means of a QubitTM fluorometer (Invitrogen, Merelbeke, Belgium). Samples
were stored at -80 ¶C. For immunodetection of CRMP-1 to -5 equal amounts of
protein (CRMP-1, -5: 10 µg, CRMP-2, -3: 15 µg, CRMP-4: 20 µg, LC3-II: 15
µg, Mfn-2, Drp1: 10 µg) were loaded onto 4-12% Bis-Tris Midi gels (Criterion
XT, Bio-Rad Laboratories, USA) and transferred to a nitrocellulose (CRMPs)
or PVDF (LC3B, Mfn-2 and Drp1) membrane. The choice of membrane was
empirically determined based on signal-to-noise ratio. Overnight incubation
with anti-CRMP-1 (1:4000, ab62709, Abcam), anti-CRMP-2 (1:10000, gift
from Dr. Y. Ihara [127], C4G), anti-CRMP-3 (1:10000, ab128875, Abcam),
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anti-CRMP-4 (1:10000, AB5454, Millipore), anti-CRMP-5 (1:5000, ab3620,
Abcam), anti-LC3B (1:1000, 2775, Cell Signaling), anti-Mfn-2 (1:1000, M6319,
Sigma) and anti-Drp1 (1:2000, ab123599, Abcam) was followed by 30 minutes
incubation with HRP-labeled secondary antibodies (1:50000, Dako, Denmark).
The immunoreactive bands were visualized using a luminol-based enhanced
chemiluminescent kit (SuperSignal West Dura, Thermo Scientific, USA). In
order to correct for inter-gel variability and to normalize the concentration
of the specific detected proteins to the total amount of protein present, we
performed a total protein stain (TPS) prior to immunodetection with LavaPurple
(Gelcompany, USA) according to manufacturer’s instructions. After the staining,
dry blots were scanned with a ChemiDocTM MP Imaging System (Bio-Rad
Laboratories, USA). The protein bands were semi-quantitatively evaluated by
densitometry (Image Lab 4.1, Bio-Rad Laboratories, USA). First, to account for
inter-gel variability including loading di erences, incomplete transfer or position
on the blot, a TPS was employed rather than the use of a single reference
protein [6, 146]. For each protein of interest, the optical density value per mouse
was normalized to its corresponding TPS. Also, to compare samples between
di erent gels, normalized data were expressed relative to the reference sample,
i.e. a pool of all samples.
3.2.3 Immunohistochemistry
WT (n = 3) and MMP-3-/- (n = 3) mice received an intraperitoneal injection of
sodium pentobarbital (Nembutal, 600 mg/kg, Ceva Sante Animale) before being
perfused transcardially with 1% paraformaldehyde (PFA, Sigma-Aldrich, St.
Louis, MO) in 0.15M phosphate-bu ered saline (PBS, pH 7.42) at 37 ¶C. Brains
were dissected and post-fixated in 4% PFA in PBS overnight after which they
were cut on a vibratome (Leica VT1000S, Leica Microsystems GmbH, Wetzlar,
Germany) into 50 µm-thick coronal sections. An indirect labeling with signal
amplification was used to visualize CRMP-5 in brain sections. Free-floating
sections were incubated with a 0.3% H2O2- in Tris-bu ered saline (TBS; 0.01M
Tris, 0.9% NaCl, 0.3% Triton-X 100, pH 7.6). After pre-incubation with Pre
Immune Goat serum (1:5 for 45 min), the sections were incubated overnight
with the primary CRMP-5 antibody (1:500, ab3620, Abcam). The following day,
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detection was performed using a biotinylated rabbit anti-goat immunoglobulin
G (1:200, 30 min, Dako, Glostrup, Denmark) and an avidin-biotin-horseradish
peroxidase solution (Vectastain Elite ABC, Vector Laboratories, Burlingame,
CA). All incubations and rinses (3x10 min) were performed in TBS. The sections
were immunostained using the glucose oxidase-diaminobenzidine-nickel method
resulting in a black staining [306, 336]. Finally, the sections were mounted on
gelatine-coated slides, air dried, dehydrated, cleared with xylene, coverslipped
and viewed under a Zeiss Axio-Imager equipped with a Zeiss Axiocam (Carl
Zeiss Benelux). Images were taken with the ZEN software (Carl Zeiss Benelux).
3.2.4 Statistics
All Western blot data are presented as mean ± SEM. A normal distribution was
verified using the Kolmogorov–Smirnov test and parallel equal variance between
groups was tested. If the test requirements were fulfilled, an unpaired Student’s
t-test for pairwise comparison was used (*P < 0.05, **P < 0.01, ***P < 0.001).
When criteria for this parametrical test were not fulfilled, a Mann-Whitney U
rank sum test for pairwise comparison of independent samples was applied (*P
< 0.05, **P < 0.01, ***P < 0.001). Statistical analyses were performed using
SigmaStat 3.1 (SYSTAT software).
RESULTS 67
3.3 Results
3.3.1 Upregulation of CRMP-5 in the visual cortex of MMP-3
deficient mice
In order to assess a possible link between the observed MMP-3-/- dendritic
phenotype and CRMP expression levels, we conducted a Western analysis for
all five CRMPs. Only CRMP-5 was significantly upregulated (P = 0.006) in
the visual cortex of MMP-3-/- mice compared with WT, whereas the protein
levels of CRMP-1,-2,-3 and -4 did not di er (figure 3.1a-e) (CRMP-1: P =
0.445; CRMP-2: P = 0.102; CRMP-3: P = 0.508; CRMP-4: P = 0.839). No
apparent di erences were observed in the cortical distribution of CRMP-5 when
comparing the CRMP-5 stained visual cortex of MMP-3-/- mice with WT.
CRMP-5 was predominantly located in the cell soma and dendrites in V1 with
the highest expression in layers II/III and a distinct expression in layer V (figure
3.2).
3.3.2 Autophagosome accumulation and mitochondrial dyna-
mics in MMP-3 deficient mice
A recent study by Brot et al. (2013) indicated that CRMP-5 induces mitophagy
to regulate mitochondria levels at the dendrite [35]. Initial stages of mitophagy
encompass the formation of autophagosomes around mitochondria that later
fuse with lysosomes. To examine a possible contribution of autophagosomes to
the MMP-3-/- phenotype, we measured the expression level of the lipidated form
of LC3, LC3-II since it initiates autophagy by insertion into autophagosomes.
Western analysis revealed a significant upregulation (P = 0.004) of a 15 kDa band
corresponding to LC3-II (figure 3.3a). A vague band at 18 kDa corresponding
to LC3-I was nearly undetectable in both conditions and was therefore not
analyzed.
A recent 2-D DIGE study on the visual cortex of MMP-3-/- and WT mice
revealed several di erential proteins associated with mitochondrial function and
dynamics. Therefore, we measured the expression levels of the mitochondrial
68 CRMP-5 AND LC3-II EXPRESSION IN THE VISUAL CORTEX OF MMP-3 DEFICIENT MICE
Figure 3.1: CRMP expression levels in the visual cortex of wildtype and MMP-3
deficient mice.
Expression levels of CRMP-1, -2, -3 and -4 did not di er in the adult visual cortex of
wildtype (WT) compared with MMP-3 deficient (-/-) mice (a-d). However, CRMP-5
was upregulated in the visual cortex of MMP-3-/- mice compared with WT with **P
< 0.01. Above each graph representative bands and their corresponding molecular
weight are shown. Values in a-d represent mean ± SEM.
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Figure 3.2: CRMP-5 immunoreactivity in the visual cortex of wildtype and MMP-3
deficient mice.
In both wildtype (WT) and MMP-3 deficient mice (-/-) CRMP-5 is predominantly
located in layers II/III and V (a,b). No apparent di erence in cellular localization was
found when comparing layer V neurons in V1 of WT and MMP-3-/- mice (c,d) since
in both conditions CRMP-5 could be detected in the soma (black arrowheads) and the
apical dendrite (gray arrowheads). Scalebars in a,b: 50 µm. Scalebars in c,d: 20 µm.
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fusion and fission proteins mitofusin-2 (Mfn-2) and dynamin-related protein 1
(Drp1) (figure 3.3b,c). The expression level of fusion protein Mfn-2 and fission
protein Drp1 did not di er between MMP-3-/- and WT mice (Mfn-2: P = 0.238;
Drp1: P = 0.326), suggesting that MMP-3 deficiency does not lead to defects
in mitochondrial fusion and fission dynamics.
Figure 3.3: Expression levels of LC3-II, Mfn-2 and Drp1 in the visual cortex of
wildtype and MMP-3 deficient mice.
The expression level of the autophagy marker LC3-II was significantly upregulated
in MMP-3-/- mice compared with WT (**P < 0.01) (a), indicating that MMP-3
deficiency leads to an increase in autophagosome generation. Expression levels of the
mitochondrial fusion protein Mfn-2 and fission protein Drp1 did not di er between
both conditions (b,c), suggesting a stable balance between fusion and fission dynamics
in MMP-3-/- mice. Above each graph representative bands and their corresponding
molecular weight are shown. Values in a-c represent mean ± SEM.
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3.4 Discussion
The previous chapter highlighted the abnormal dendritic architecture of layer
V pyramidal neurons in the visual cortex of MMP-3-/- mice, characterized by a
reduction in apical dendritic length and spine length (chapter 2) [3]. To better
understand this phenotype on a molecular level we focused on the family of
collapsin response mediator proteins, autophagy and mitochondrial dynamics.
3.4.1 Upregulation of CRMP-5 as a potential cause of the
MMP-3 deficient dendritic phenotype
Western analysis of all five CRMPs revealed an upregulation of CRMP-5 in
the visual cortex of MMP-3-/- mice compared with WT, whereas the levels of
other CRMPs did not di er (figure 3.1). Interestingly, CRMP-5 is necessary to
specifically suppress dendritic outgrowth during development by inhibiting
tubulin polymerization and counteracting the growth-promoting e ects of
CRMP-2, with CRMP-5 being the dominant signal [36, 37]. In agreement with
our data, immunohistochemical localization of CRMP-5 has been previously
reported in the soma and apical dendrites in the cortex of adult mice, whereas
axons only express CRMP-5 at embryonic stages [32] (figure 3.2c,d). The
same study indicated that CRMP-5 expression was mainly located in layer V
pyramidal cells in the adult cortex, whereas we observed the highest expression
in layers II/III (figure 3.2a,b). Although this could be in part the result of
di erent specificities of the antibodies used in both studies. Taken together,
both the involvement of CRMP-5 in dendritic outgrowth and the localization
of CRMP-5 in pyramidal neurons provides a reasonable explanation for the
truncated dendritic phenotype observed in MMP-3-/- mice [3].
It should be noted that the expression of several CRMPs, including CRMP-5 is
downregulated during development [44] and the exact function of CRMPs in
the adult brain remains elusive [291, 32]. Several studies indicate that CRMPs
are also involved in spine maturation, synaptic plasticity and maintenance of
neuronal circuits [34, 358, 373, 372] and CRMP-2 is a known substrate of MMP-9
[13]. Importantly, it is known that CRMP-5 is able to form heterooligomers with
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other CRMPs , except CRMP-1 [113]. As a result, an upregulation of CRMP-5
could alter the function of these hetero-CRMP complexes. Interestingly, CRMP-
5 and other CRMPs can modulate semaphorin 3A (Sema3A) signaling, both in
development and the adult brain [291, 144]. Sema3A serves as a chemoattractant
for the apical dendrites of cortical pyramidal neurons [278] and regulates the
expression and activity of MMP-3 in the cortex [123], providing a possible
link between CRMP-5 and MMP-3. Similarly, in the cerebellum of CRMP-5-/-
mice the diameter of primary dendrites of Purkinje cells is decreased [373]
and MMP-3-/- mice display a reduced Purkinje cell dendritic tree size [339],
indicating that both CRMP-5 and MMP-3 are involved in the development and
maintance of Purkinje cells. In summary, CRMP-5 can be put forward as a
putative, underlying mediator of the altered dendritic architecture and cortical
plasticity observed in MMP-3-/- mice [3].
3.4.2 MMP-3 deficiency elevates autophagosome generation
but does not alter mitochondrial fusion and fission
dynamics
A recent study by Sebastien Brot and colleagues indicated that CRMP-5 is
located in mitochondria in vivo and regulates mitophagy by recruiting lysosomes
at the mitochondrial level, thereby reducing the number of mitochondria in
dendrites [35]. The initial stage of mitochondrial degeneration is the formation
of autophagosomes [379] and is characterized by the conversion of LC3-I to
the lipidated form LC3-II which inserts in the autophagosome membrane [322,
70, 35]. To examine whether CRMP-5 overexpression in MMP-3-/- mice can
potentially mediate autophagosomal content, we performed Western analysis
on LC3. MMP-3-/- mice displayed a signifcant upregulation of LC3-II in the
visual cortex compared with WT (figure 3.3), indicative for autophagosome
accumulation and mitophagy initiation. In accordance with these results,
Brot et al. showed that overexpression of CRMP-5 in hippocampal neurons
leads to an upregulation of LC3-II [35]. However, based on our data we can
not conclude that this increase in LC3-II translates to increased autophagy
because we did not measure the entire dynamic process of autophagy termed the
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autophagic flux [229, 388]. LC3-II is located at the outer and inner membrane
of the autophagosome and can be partially degraded when autophagosomes
fuse with lysosomes. If LC3-II still increases after adding lysosomal inhibitors
to the sample, this would indicate an enhancement of autophagic flux [229].
Measuring the relative abundance of LC3-II alone serves as an indicator for the
amount of autophagosomes in the sample and provides a first indication to an
increase in autophagy [229]. It is still possible however that the autophagosome
accumulation is a result of autophagic inhibition by for example blockage of
autophagosome-lysosome fusion [322, 176, 388]. It would be interesting to
additionally examine the levels of lysosomal markers and evaluate the number
of mitochondria by means of immunohistochemistry or electron microscopy to
establish a definitive role for increased mitophagy in MMP-3-/- mice. We did not
observe clear immunoreactivity for LC3-I in our Western analysis although the
antibody used in this study has been extensively used for measuring both LC3-I
and LC3-II in rodent brain samples [191, 91, 35, 320, 190]. This discrepancy
might be explained by a di erences in sample preparation methods combined
with the antibody’s preference to LC3-II [229].
We observed no di erences in expression levels of mitochondrial fusion and
fission proteins Mfn-2 and Drp1, indicating that a normal balance between
fusion and fission is retained in MMP-3-/- mice. In accordance to this study,
overexpressing CRMP-5 in hippocampal neurons did not have any e ect on Drp1
levels [35], although the process of autophagy is linked to mitochondrial fusion
and fission [379]. However, we did not evaluate the levels of other fusion and
fission proteins such as Mfn-1, OPA1 and Fis1 which also regulate mitochondrial
dynamics in concert with Mfn-2 and Drp1 [201].
3.4.3 Conclusions
This study evidences that genetic inactivation of MMP-3 has significant e ects
on the expression level of CRMP-5, whereas the cortical distribution of this
phosphoprotein does not change apparently compared with WT mice. The
observed overexpression of CRMP-5 provides a potential basis for the observed
dendritic phenotype in MMP-3-/- mice. However, since we only studied CRMP
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expression in the adult cortex, other processes may be at play related to the
elusive role of CRMP-5 in the adult brain. Changes in LC3-II expression
also hint towards a role for autophagy which could provide a framework for
the cortical phenotype of MMP-3-/- mice by dysregulation of mitochondrial
dynamics. In any case, further experiments are needed to establish a definitive
role for autophagy and mitophagy in these knockout mice.
Chapter 4
Monocular enucleation a ects the expression of
specific MMPs in an age-dependent manner
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4.1 Introduction
Matrix metalloproteinases (MMPs) constitute a family of Zn2+-dependent
endopeptidases that can be considered as key nodal components of a complex
protease web [295]. In addition to the implication of MMPs in various CNS
pathologies, MMPs have a beneficial role in shaping neural connections and
modulating structural and functional plasticity [97, 227, 225]. For example,
inhibition of MMP-3 and MMP-9 in the hippocampus of rats abolished spatial
learning in a Morris water maze task by impairing long-term potentiation (LTP)
[216, 368]. Recently, Spolidoro et al. (2012) uncovered a role for MMPs in ocular
dominance plasticity in the visual cortex of monocular deprived juvenile rats.
Infusion of a broad-spectrum MMP inhibitor prevented both the potentiation
of the open-eye response and the concomitant increase in spine density on layer
II-III pyramidal neurons after MD, indicating a role for MMPs in regulating
structural and functional plasticity in the visual system [309]. As highlighted
in the previous chapter, adult MMP-3 deficient (MMP-3-/-) mice displayed
an impaired monocular enucleation (ME)-induced open-eye potentiation and
cross-modal plasticity in the visual cortex (chapter 2) [3]. Earlier work in adult
P120 C57Bl/6J mice provided evidence for an extensive reactivation of the visual
cortex within seven weeks post-ME [334, 256]. This reactivation was driven by
an initial open-eye potentiation followed by cross-modally driven plasticity in
the medial an lateral monocular zones starting from adjacent non-visual cortices
around three weeks post-ME [334]. However, P45 C57Bl/6J mice subjected
to the ME paradigm displayed a lack of cross-modal plasticity seven weeks
post-ME, indicating that the potential for ME-induced cross-modal plasticity
in the visual cortex is age-dependent in C57Bl/6J mice [256]. In relation to
the data presented in chapter 2 and the fact that the cross-modal plasticity
response of MMP-3-/- mice resembles that of P45 mice (figure 1.4) [256], MMP-3
can be put forward as a potential candidate for regulating the age-dependent
component of cortical plasticity. Therefore, in this study we evaluated the
expression level of MMP-3 using Western analysis in the medial monocular zone
and binocular zone of both P45 and P120 ME mice to unravel a potential role
of this enzyme in cross-modal plasticity and open-eye potentiation. In the same
conditions we examined the levels of MMP-2 and MMP-9 using a combination
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of Western analysis and gelatin zymography. Finally, we attempted to optimize
a fluorescent assay to measure the activity of MMP-3 in homogenized brain
samples.
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4.2 Material and methods
4.2.1 Animals
All experiments were performed in C57Bl/6J mice obtained from Janvier Elevage
(Le Genest-St-Isle, France), which were housed under standard laboratory
conditions under an 11/13h dark/light cycle with food and water available ad
libitum. All experiments have been approved by the Ethical Committee of
the university and were in strict accordance with the European Communities
Council Directive of 22 September 2010 (2010/63/EU) and with the Belgian
legislation (KB of 29 May 2013). Every possible e ort was made to minimize
animal su ering and to reduce the number of animals.
4.2.2 Monocular enucleation
Monocular enucleation of the mice (n = 3 / condition) was performed as
previously described [2, 256, 333]. Briefly, under anesthesia by intraperitoneal
injection of a mixture of ketamine hydrochloride (75 mg/kg, Dechra Veterinary
Products, Eurovet) and medetomidine hydrochloride (1 mg/kg, Orion
Corporation, Janssen Animal Health), the right eye was carefully removed
and if needed, the orbit was filled with hemostatic cotton wool (Qualiphar,
Bornem, Belgium). After injection with atipamezol hydrochloride (1 mg/kg,
Orion Corporation, Elanco Animal Health) to reverse anesthesia, the animals
were allowed to recover on a heating pad. They were all administered 0.05 ml
of antibiotics (Kefzol, 1 g Natrii cefazolin and 15 mg Lidocaini hydrochloridum
anhydricum in 4 ml 0.9% NaCl, Eurocept Pharmaceuticals) intramuscularly to
prevent post-surgical infections. After the enucleation procedure, mice were
again housed under the same normal light conditions in standard cages for a
survival period of one, three or seven weeks. Prior to sacrifice, the animals
underwent an overnight dark-exposure followed by 45 min of bright light.
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4.2.3 Western Blotting
The expression profiles of di erent MMPs was examined in the visual cortex of
P45 and P120 mice one, three and seven weeks post-ME. To assess the MMP
expression before manipulation we included samples of P45 and P120 mice
without ME. For each mouse (n = 3 / condition) the monocular and binocular
visual cortex was collected from 100 µm-thick coronal cryosections spanning
Bregma levels -2.00 to -4.60. Proteins were extracted in a modified RIPA bu er
(50 mM Tris HCl, 300 mM NaCl, 0,5 % Triton, 0,5 % sodium deoxycholate,
0,1 % SDS, pH 7.8) and the samples were sonicated and heated for 5 minutes
at 70 ¶C. Next, the samples were centrifuged (10000 x g) for 5 minutes at
4 ¶C. The supernatant was isolated and the total protein concentration was
determined by means of a BCA protein assay kit (Pierce, Thermo Scientific).
Samples were stored at -80 ¶C. For immunodetection of MMP-2 and MMP-3
equal amounts of protein (10 µg) were loaded onto 4-12% Bis-Tris Midi gels
(Criterion XT, Bio-Rad Laboratories, USA) and transferred to a polyvinylidene
fluoride (PVDF) (MMP-3) or nitrocellulose (MMP-2) membrane. The choice of
membrane was empirically determined based on signal-to-noise ratio. Overnight
incubation with anti-MMP-2 (1:100, sc-8835-R, Santa Cruz) and anti-MMP-3
(1:100, ab52915, Abcam) was followed by 30 minutes incubation with HRP-
labeled secondary antibodies (1:50000, Dako, Denmark). All antibodies were
previously validated in other tissues and with recombinant MMPs as positive
controls (for MMP-3 specifically see [338]). We also tested di erent anti-
MMP-9 antibodies, without succes: 1:500-1:5000; ab137867, ab104686 and
ab38898 (Abcam), AB19016 (Millipore) and two antibodies made in the lab
of Prof. dr. G. Opdenakker (KU Leuven). The immunoreactive bands were
visualized using a luminol-based enhanced chemiluminescent kit (SuperSignal
West Dura, Thermo Scientific, USA). In order to correct for inter-gel variability
and to normalize the concentration of the specific detected proteins to the
total amount of protein present, we performed a total protein stain (TPS)
prior to immunodetection with LavaPurple (Gelcompany, USA) according to
manufacturer’s instructions. After the staining, dry blots were scanned with a
ChemiDocTM MP Imaging System (Bio-Rad Laboratories, USA). The protein
bands were semi-quantitatively evaluated by densitometry (Image Lab 4.1,
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Bio-Rad Laboratories, USA). First, to account for inter-gel variability including
loading di erences, incomplete transfer or position on the blot, a TPS was
employed rather than the use of a single reference protein [6, 146]. For each
protein of interest, the optical density value per mouse was normalized to its
corresponding TPS. Also, to compare samples between di erent gels, normalized
data were expressed relative to the reference sample, i.e. a pool of all samples.
4.2.4 MMP-3 activity assay
To asses the age-dependent e ect of ME on MMP-3 activity in the visual cortex
we measured the MMP-3 activity levels in adolescent (P45) and adult (P120)
mice at three, five and seven weeks post-ME. For each group we included
age-matched controls to allow a correct interpretation of the data. For each
mouse (n = 3 / condition) the complete visual cortex was collected from 100
µm-thick coronal cryosections spanning Bregma levels -2.00 to -4.60. Proteins
were extracted in a TCNB bu er (50 mM Tris, 10 mM CaCl2, 150 mM NaCl,
0.05 % Brij-35, 1 % Triton X-100, pH 6.5 and EDTA-free protease inhibitor
cocktail (Roche Diagnostics Ltd, Mannheim, Germany)) and the samples were
centrifuged (10000 x g) for 15 minutes at 4 ¶C. The supernatant was isolated
and the total protein concentration was determined by means of a BCA protein
assay kit (Pierce, Thermo Scientific). Samples were stored at -80 ¶C.
The proteolytic activity of MMP-3 was assessed fluorometrically using a 5-
FAM/QXL520 fluorescence resonance energy transfer (FRET) peptide (60580,
Anaspec, San Jose, CA) according to a modified protocol adapted from
Candelario-Jalil et al. 2011 [39]. We applied two di erent approaches to
optimize the protocol for measuring MMP-3 activity in mouse brain tissue,
focusing on the use of di erent protein A/G beads for immunocapturing MMP-3
(figure 4.1). To immunoprecipitate MMP-3 from the samples, 2 µg/ml of a
monoclonal rabbit anti-MMP-3 antibody (ab52915, Abcam) was incubated
with 20 µl protein A/G agarose beads (sc-2003, Santa Cruz Biotechnology) or
magnetic beads (88802, Thermo Scientific). This mixture was added to 500 µg
sample and incubated overnight at 4 ¶C while gently rocking. Samples were
centrifuged at 1000 x g for 5 minutes at 4°C and supernatant was discarded. The
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pellet containing the agarose beads was resuspended in TCNB bu er and was
added onto a Ultra-free MC filtertop (UFC30GV00, Millipore) in an eppendorf
tube to specifically isolate the beads. Next, the samples were centrifuged at
1000 g for 2 minutes at 4°C and the fluid in the eppendorf tube was discarded.
The filtertop was turned upside down and 100 µl assay bu er (50 mM Tris,
10 mM CaCl2, 200 mM NaCl, 20 mM ZnSO4, 0.05 % Brij-35, pH 6.5) was
added before centrifugation (1000 g for 2 minutes at 4°C). When performing
immunoprecipitation using the magnetic beads, the antibody-bead complex
was pulled down with a magnet and supernatans was discarded. Additional
washing steps were performed with TCNB bu er and in the final step assay
bu er was added. For both the agarose and magnetic beads procedure, all
samples were incubated with the FRET peptide in a 96-well plate at 37 ¶C with
gentle rocking. Every well contained a pool of three mice samples of the same
condition and every well was made in duplicate. Fluorescence was measured
every hour at 37 ¶C with 485ex/538em using a Flexstation II microplate reader
(Molecular Devices) every hour for eight hours. A substrate control was added
and this fluorescent value was subtracted from the fluorescent values of the
samples to obtain relative fluorescence units (RFU). To examine the e ect of
beads on the fluorescent signal we included a control with agarose beads or
magnetic beads and FRET substrate in assay bu er.
4.2.5 Gelatin zymography
Samples (n = 4 / condition) were collected and processed identically to the
samples for the MMP-3 activity assay with the TCNB bu er put to pH 7.6.
Samples of the medial monocular visual cortex of each mouse of the same
condition were pooled together to perform a pilot study and 90µg of each
pooled sample was first prepurified by gelatin-Sepharose a nity chromatography
(described in detail in [73]). Next, the proteins were separated in 7.5%
polyacrylamide gels to which 0.1% gelatin (Sigma-Aldrich, St Louis, MO, USA)
was added and copolymerized. After electrophoresis, the gels were washed
with Triton-X 100 to remove sodium dodecyl sulfate and incubated for the
development of zymolytic bands. The gels were stained with Coomassie brilliant
blue R-250 (Sigma-Aldrich, St Louis, MO, USA). For this pilot study we included
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Figure 4.1: Schematic overview of the MMP-3 enzymatic activity assay.
Brain samples were either incubated with protein A/G agarose (a) or magnetic (b)
beads coupled to anti-MMP-3. A filtertop was used to purify the agarose beads
whereas the magnetic beads were pulled down using a magnet. The beads were
then transferred to a 96-well plate and a FRET substrate was added to quantify the
proteolytic activity of MMP-3.
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recombinant MMP-9 and pools of the following conditions: P45 and P120 mice
one, three and seven weeks post-ME. The zymography procedure was conducted
by the lab of Prof. dr. G. Opdenakker (KU Leuven).
4.2.6 Statistics
All Western blot data are presented as mean ± SEM. A normal distribution was
verified using the Kolmogorov–Smirnov test and parallel equal variance between
groups was tested. If the test requirements were fulfilled, an unpaired Student’s
t-test for pairwise comparison was used (*P < 0.05, **P < 0.01, ***P < 0.001).
When criteria for this parametrical test were not fulfilled, a Mann-Whitney U
rank sum test for pairwise comparison of independent samples was applied (*P
< 0.05, **P < 0.01, ***P < 0.001). Statistical analyses were performed using
SigmaStat 3.1 (SYSTAT software).
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4.3 Results
4.3.1 Age-dependent e ect of monoculear enucleation on
MMP-3 expression levels
To di erentiate between MMP-3 expression involved in ME-induced cross-modal
plasticity and open-eye potentiation, we analyzed the medial monocular zone
(Mmz) and the binocular zone (Bz) of the visual cortex respectively, using
Western analysis in P45 and P120 mice. Expression levels of MMP-3 showed
significant di erences across post-ME survival times and age (figure 4.2). In
the Mmz of P45 control mice proMMP-3 was significantly higher expressed
compared with P120 controls (P = 0.004, figure 4.2a), indicating that age itself
has an influence on the total amount of proMMP-3 present in the visual cortex.
In P45 mice one week post-ME proMMP-3 is downregulated (P = 0.017) and
returns to control levels following three (P = 0.119) and seven weeks (P =
0.969) ME. Interestingly, in the Mmz of P120 mice no fluctuations in proMMP-3
expression levels was observed in relation to post-ME survival time (figure 4.2a).
In the Bz the proform of MMP-3 remains downregulated up to seven weeks
post-ME compared to control (3wME: P = 0.010; 7wME: P = 0.004) in P45
mice whereas in P120 mice the expression level is significantly higher at seven
weeks post-ME compared with three weeks (P = 0.009) (figure 4.2b). Taken
together, proMMP-3 levels in both the Mmz and Bz are di erentially regulated
post-ME in an age-dependent manner with the largest modulation observed in
P45 mice. This suggests that MMP-3 may contribute to limiting the potential
for cross-modal plasticity in the visual cortex. Importantly, we did not detect
the active form of MMP-3 in our samples.
4.3.2 Optimization of an enzymatic activity assay for MMP-3
Since only the proform of MMP-3 was detected using Western analysis, e orts
were taken to optimize a fluorescent activity assay to measure the net MMP-3
activity in P45 and P120 ME samples. We therefore adapted an existing protocol
from Candelario-Jalil et al. (2011) [39] to optimize it for measuring MMP-3
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Figure 4.2: Age-dependent expression levels of MMP-3 in the medial monocular and
binocular zone after enculeation.
ProMMP-3 expression levels di er in function of age and post-ME survival time, both
in the medial monocular zone (Mmz) (a) and binocular zone (Bz) (b) with *P <
0.05, **P < 0.01, ***P < 0.001. Above each graph representative bands and their
corresponding molecular weight are shown. Values in a-b represent mean ± SEM.
Abbreviations: C, control; ME, monocular enucleation; OD, optical density; w, week.
in brain tissue. We incubated the MMP-3 antibody with the protein A/G
beads before applying this complex to the homogenized sample (figure 4.1). In
addition, two di erent approaches to immunocapture MMP-3 from homogenized
visual cortex samples were tested to reassure the specificity of measuring MMP-3
proteolytic activity with a FRET peptide. One approach utilized protein A/G
agarose beads and the other encompassed the use of protein A/G magnetic
beads to bind an MMP-3 antibody to capture the enzyme in the samples (figure
4.1). Since the agarose beads resuspend easily after centrifugation, we opted for
the use of a filtertop as described in figure 4.1. We first tested which type of
beads resulted in the best signal to noise ratio in the proposed assay. When
comparing the baseline fluorescence of the FRET substrate incubated with and
without antibody-bearing beads, only incubation with magnetic beads resulted
in a decreased signal (figure 4.3a). In addition, samples immunoprecipitated
with either agarose or magnetic protein A/G beads resulted in a higher signal
in agarose beads than the magnetic beads condition (figure 4.3b). These results
clearly indicate that using magnetic beads influences the readout of the assay
and therefore we continued to only use the agarose beads for immunocapturing
MMP-3 (figure 4.1a).
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Figure 4.3: Optimization of MMP-3 immunoprecipitation from mouse brain samples.
Baseline fluorescence was measured after 4h incubation in a control containing only
assay bu er and FRET substrate, a condition with agarose beads and substrate and a
condition with magnetic beads and substrate (a). MMP-3 from visual cortex samples
was immunoprecipitated with either agarose or magnetic beads and the concomitant
RFU was normalized to a substrate control (b). Both graphs (a-b) show a decrease in
fluorescent signal when using magnetic beads, indicating that these beads influence
the fluorescent readout of the assay. Abbreviations: RFU, relative fluorescence units.
To assess the age-dependent e ect of ME on the proteolytic activity of MMP-3
in the visual cortex we compared samples of P45 and P120 old mice seven
weeks (w) post-ME including age-matched controls (AMC) and P45 and P120
MMP-3-/- controls. The MMP-3-/- samples served as an age-dependent baseline
for MMP activity, since the immunoprecipitation of MMP-3 was never expected
to be 100% pure and small traces of other proteases in the sample would be
detected with this sensitive assay. However, the RFU values of the MMP-3-/-
control samples were in the same range as the C57Bl/6J samples, indicating
that this assay was not able to obtain representative MMP-3 activity levels in
the tested brain samples.
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4.3.3 MMP-2 expression and gelatinolytic activity in the
visual cortex after monocular enucleation
In addition to MMP-3, we wanted to focus on MMP-2 and MMP-9 since
these MMPs are the most widely studied and the function of MMP-9 in
synaptic plasticity is well established. To study the gelatinases we used a
combination of Western analysis and the gelatin zymography for the detection
of gelatinase activity. In the Western analysis for MMP-2 none of the conditions
revealed di erences in expression level (figure 4.4a-d). This indicates that
MMP-2 protein expression does not alter in an age-dependent manner after
monocular enucleation and suggest that this enzyme does not actively mediate
age-dependent cortical plasticity. Of note, no suitable antibody for MMP-9 to
perform Western analysis was available.
To assess di erences in age-dependent ME-induced gelatinolytic activity, we
conducted a pilot study on samples of the Mmz and pooled the mice for each
condition. In none of the conditions tested we were able to detect any amount
of MMP-9 activity, whereas MMP-2 activity was clearly visible (figure 4.5). No
apparent di erences in MMP-2 activity levels were observed between P45 and
P120 samples or the examined post-ME survival times, similar to what was
found in the Western analysis.
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Figure 4.4: Age-dependent expression levels of MMP-2 in the medial monocular and
binocular zone after enculeation.
Both the expression levels of the proform and active form in the medial monocular
zone (Mmz) (a-b) did not di er significantly after enucleation in P45 and P120 mice.
This was also the case in the binocular zone (Bz) (c-d), together indicating that
MMP-2 may not play a role in age-dependent ME-induced cortical plasticity. Above
each graph representative bands and their corresponding molecular weight are shown.
Values in a-d represent mean ± SEM. Abbreviations: C, control; ME, monocular
enucleation; OD, optical density.
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Figure 4.5: Zymogram with MMP-2 and MMP-9 activity in pooled samples of
medial monocular visual cortex after enucleation.
No apparent di erences in zymolytic activity corresponding to MMP-2 is detected
between di erent post-ME survival times in P45 and P120 mice. No distinct bands
corresponding to MMP-9 activity are discernible, suggesting that proteolytic activity
of MMP-9 in the medial monocular zone of visual cortex is below the detectable
threshold. Abbreviations: ME, monocular enucleation; w, week.
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4.4 Discussion
4.4.1 Optimization of a fluorescent assay for measuring MMP-
3 activity
In this study we tested a protocol to measure the activity of MMP-3 in mouse
visual cortex samples. To accomplish this we modified an existing protocol from
Candelario-Jalil et al. (2011) [39]. In this original protocol, the researchers
incubated the samples with MMP-3 antibody before adding protein A/G beads.
However, MMP-3 is capable of cleaving the Fc-fragment of human and mouse
immunoglobulin G (IgG) antibody isotypes [117] rendering the anti-MMP-3
antibody unable to bind to the protein A/G beads. The MMP-3 antibody used
in this study is a rabbit IgG which contains a similar MMP-3 cleavage site. In an
attempt to prevent cleavage of the antibody prior to binding protein A/G beads,
we therefore incubated the antibody with the beads before immunocapturing
the enzyme in the samples. To ensure proper purification of the MMP-3 bearing
antibody-coupled beads we tested both agarose and magnetic protein A/G beads
(figure 4.1). We consistently observed lower RFU values when measuring MMP-3
proteolytic activity using the magnetic beads (figure 4.3). One reason could be
that there is a di erence in IgG binding capacity between the two types of beads
resulting in a di erent amount of enzyme being immunoprecipitated. However,
the magnetic beads have a binding capacity of 55 µg to 85 µg IgG per mg beads
which is in the range of high capacity agarose beads and therefore a di erence in
binding capacity can not account for the consistent lower RFU values measured
when using magnetic beads. A possible explanation for the observed di erence
in RFU values is that magnetic beads consist partially of magnetite which is
able to absorb light with a wavelength around 485 nm, used to excite the FRET
substrate [321]. A solution to this problem would be to use a near-infrared
(NIR) FRET substrate to minimize the light absorption of the magnetite-
containing magnetic beads. Several studies report the development of NIR
FRET substrates for MMPs [119, 242] but to our knowledge no such substrate
specifically targeting MMP-3 is commercially available. Therefore we opted to
use agarose protein A/G beads combined with filtertops to specifically isolate
the beads from the sample (figure 4.1a). Applying this strategy to measure the
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MMP-3 activity in the visual cortex of P45 and P120 mice after monocular
enucleation (ME) revealed a considerable amount of proteolytic activity in the
included MMP-3-/- control samples, indicating that the assay is not specific for
MMP-3. This could be the result of aspecific binding of proteins, including other
MMPs or proteases to antibody and/or beads, sometimes referred to as the
bead proteome [329]. One way to resolve this is to pre-clean the samples by first
introducing beads coupled to a non-target antibody to remove all proteins that
bind aspecifically to the antibody-bead complex. Finally, the FRET substrate
used in this study has only been tested against MMP-1, -2, -3 and -9 and is
herein specific for MMP-3 [244]. However, it is still possible that other MMPs
or proteases in the bead proteome can cleave this substrate, resulting in the
observed signal in the MMP-3-/- control mice.
4.4.2 MMP expression profiles are di erentially regulated
upon ME
To assess whether MMPs are involved in regulating ME-induced age-dependent
cortical plasticity we examined the levels of MMP-2 and MMP-3 using Western
analysis and performed gel zymography to assess the activity potential of MMP-2
and MMP-9. Expression levels of proMMP-3 did fluctuate significantly according
to age and post-ME survival time, especially in P45 mice and both in the Mmz
and Bz (figure 4.2a-b), suggesting that this enzyme is potentially involved in
ME-induced cortical plasticity. Western analysis revealed no di erences in
expression level of pro- and active MMP-2 in all conditions tested (figure 4.4a-d)
and this was also apparent in the gelatin zymography study (figure 4.5). Finally,
we were not able to detect levels of MMP-9 using gelatin zymography (figure
4.5).
ME-induced cortical plasticity is thought to rely on axonal sprouting and
structural and functional changes in synaptic contacts, rather than inducing
gross changes to dendritic arbors. As a similar type of sensory manipulation,
removal of whiskers in adult mice induced axonal sprouting and an increase in
spine density on layer V pyramidal neurons in the spared barrel concomitant with
a reduction in spine density in layer II/III pyramids in the deprived barrel [181].
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In that regard, MMPs are known to regulate cytoskeletal dynamics underlying
neurite growth and spine dynamics and several intracellular substrates of MMPs
constitute cytoskeletal proteins [224, 338, 40]. Moreover, a recent study by
Spolidoro et al. (2012) revealed that broad-spectrum inhibition of MMPs in the
binocular zone of juvenile rats specifically prevents the open-eye potentiation
and the increase in filopodia-like spines on basal dendrites of layer II/III
pyramidal neurons after seven days of MD [309]. Together with a large body
of evidence obtained in the hippocampus, MMPs have an established role
as modulators of the structural and functional properties of dendritic spines
[224, 247, 102, 361, 252, 325, 26] which makes them ideal candidates to modulate
the ME-induced open-eye potentiation and cortico-cortical networks for cross-
modal plasticity.
Accumulating evidence suggests that recalibration of the excitation-inhibition
balance is responsible for regulating plasticity in the visual cortex [130, 136,
22, 100, 165, 140, 139, 212]. Interestingly, recent work in our lab revealed
that 7wME of both P45 and P120 mice induced an upregulation of inhibitory
markers such as GAD65/67 but only P45 mice displayed an additional increase
in GABAAR–1 levels in the medial monocular zone (Nys et al., submitted).
Recent immunohistochemical analysis of MMP-3 in the barrel cortex displayed
a punctate pattern with puncta primarily located at the cell soma of pyramidal
neurons, suggesting that MMP-3 is possibly associated with GABAergic synapses
(personal communication with dr. G. Wiera, lab of prof. J. W. Mozrzymas).
Perisomatic inhibition of pyramidal neurons is carried out by parvalbumin-
positive fast-spiking interneurons which are surrounded by perineuronal nets
(PNN) (figure 4.6) [7, 139]. Main components of PNN are the chondroitin
sulphate proteoglycans which are known substrates of several MMPs, especially
MMP-3 [239, 237]. Although we do not have information about the expression
of active MMP-3, the age-dependent di erences in proMMP-3 expression levels
could represent changes in PNN structure which in turn modulates inhibitory
transmission in cortico-cortical networks involved in ME-induced cross-modal
plasticity. In that regard it would be interesting to assess the structure of
PNN in both control and enucleated P45 and P120 mice. Furthermore, a
high degree of structural plasticity reflected by dendritic branch tip remodeling
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and spine dynamics of GABAergic interneurons in the visual cortex has been
shown to occur across the lifespan and contributes to adult plasticity following
sensory deprivation [189, 47, 169]. MMPs could in this case also modulate
GABAergic signaling through modulation of the cytoskeleton or regulation of
GABA receptor clustering.
Figure 4.6: Schematic representation of perisomatic inhibtion by parvalbumin-
positive interneurons.
Fast-spiking, parvalbumin-immunoreactive interneurons regulate perisomatic inhibition
on pyramidal neurons and are ensheated by lattice-like structures called perineuronal
nets. Perineuronal nets ensure the proper functioning of inhibitory interneurons and
limit structural and functional plasticity in the visual cortex. Adapted from [139].
In this study we did not find any di erences in expression levels or zymolytic
activity of MMP-2 after ME in the visual cortex of both P45 and P120,
suggesting that MMP-2 is not involved in regulating ME-induced cortical
plasticity. The present evidence for the involvement of MMP-2 in synaptic
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plasticity is circumstantial. This gelatinase cleaves similar substrates as MMP-9
involved in synaptic plasticty and spine morphology, for example ICAM-5,
—-dystroglycan and several actin-related proteins [40, 344]. Moreover, MMP-2
deficient mice are impaired in their short-term working memory [228], but in
contrast to MMP-9, direct functional evidence for MMP-2 in plasticity is still
lacking [344]. In contrast to our study, MMP-9 was readily detectable using
gelatin zymography in the barrel cortex of adult mice. One week after removal
of the whiskers, MMP-2 and MMP-9 zymolytic activity was increased [163]. In
the developing and adult rat visual cortex MMP-2 and MMP-9 were detectable
using both in situ and gel zymography [317]. A possible explanation for the lack
of MMP-9 zymolytic activity in this study is the sample preparation. During
sectioning of the tissue, the brain sections inevitably have to thaw before storage
at -80 ¶C which could influence enzyme stability. In addition, to collect all
brains and sections, samples were stored for two to three months at -80 ¶C
before proceeding with the lysis. Plasma samples stored for three months at
-80 ¶C show a 40% reduction in MMP-9 activity [297] which could partly explain
why we are not able to detect any zymolytic bands in our analysis. However,
it is possible that ME does not induce upregulation of MMP-9 activity above
the detection threshold because the subset of MMPs that alter their expression
after injury depends on the nature of the injury itself [377]. Because we did
not include control samples in the pilot study, it is also possible that MMP-9 is
downregulated upon ME. In addition, the peak of MMP-9 activity could also
be achieved before the first measured time point of 1wME or between 1wME
and 5wME and analyzing zymolytic activity at earlier and intermediate time
points could resolve this issue. Of note, other MMPs could also play a role. For
example, MMP-7 is able to alter the structural and functional properties of
dendritic spines [26, 319].
Based on the changes observed in the levels of MMP-3, which mainly occur in
P45 mice, it could be that MMP-3 is necessary to inhibit the cortico-cortical
processes that govern cross-modal plasticity. However, it is very di cult to
interpret the obtained results for MMP-3 to unravel a possible function of this
enzyme in age-dependent ME-induced cortical plasticity, for two reasons: 1)
we could only detect the proform of MMP-3 which makes assumptions about
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MMP-3 activity unreliable and 2) we did not include age-matched controls
in the Western analyses. Age-matched controls are necessary to correctly
interpret the ME-induced changes in MMP expression level and to distinguish
these changes from normal age-dependent fluctuations in MMP expression
[86, 19, 332]. The latter is partly reflected in the higher proMMP-3 expression
in P45 compared with P120 control mice. Important to note is that we did not
provide a causal link between MMP expression and regulation of ME-induced
cross-modal plasticity. However, these results could serve as a basis for future
experiments wherein MMPs can be activated or inhibited at key time-points to
modulate the outcome of these age-dependent cross-modal plasticity processes
in the visual cortex.
4.4.3 Conclusions
This study illustrates that the levels of proMMP-3 in the visual cortex are
significantly altered upon ME in an age-dependent manner whereas MMP-2
expression does not di er and MMP-9 is seemingly undetectable. However,
measuring in vivo levels of MMP activity remains challenging as proven by the
attempted optimization of a fluorescent MMP-3 activity assay which did not
meet the expected reproducibility. The obtained results could serve as a guide
for future experiments focused on the targeted inhibition and/or activation
of MMPs in the visual cortex to uncover a causal relationship between MMP
activity and age-dependent ME-induced cortical plasticity.

Chapter 5
General discussion and future
perspectives
5.1 Concluding remarks on the study of MMP-3
deficient mice
Chapter 2 and 3 of this manuscript revealed a striking cortical phenotype
of MMP-3 deficient (MMP-3-/-) mice which is characterized by a truncated
dendritic architecture of layer V pyramidal neurons in the visual cortex. A
reduced length of the apical dendrite was accompanied by a reduced length of
dendritic spines on the apical shaft. Moreover, the number of apical obliques
was comparable to that of wildtype (WT) mice meaning that, in combination
with the reduced length of the apical dendrite, layer V pyramidal neurons
of MMP-3-/- mice appeared to be more branched. On a molecular level the
visual cortex of MMP-3-/- mice was characterized by an upregulation of di erent
neurofilament protein subunits, collapsin response mediator protein-5 (CRMP-5)
and the phosphatidylethanolamine-conjugated form of microtubule-associated
protein 1 light chain 3 (LC3-II) which together suggest alterations in cytoskeletal
dynamics, mitochondrial dynamics and autophagy.
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An important remark to interpret the results described in this dissertation is
that studying a gene-knockout mouse in the adult stage primarily informs one
about the response of a complex organism to the loss of a gene product, rather
than answering questions about the acute in vivo function of that gene product.
This is especially true for multi-functional proteolytic enzymes such as MMPs,
since the loss of one MMP generates gross changes in a complex degradome
which can alter numerous individual and interconnected pathways known as the
protease web [81, 295]. MMPs are key nodal components in this protease web
which renders the interpretation of MMP gene-knockout mice very di cult [295].
Unraveling a structural, functional and molecular phenotype of MMP deficient
mice can provide valuable insights into specific mechanistic properties of the
protease web. Indeed, the extreme structural phenotype in the visual cortex
of MMP-3-/- enables us to learn more about pyramidal neuron morphology in
relation to cortical processing and plasticity.
5.2 E ects of MMP-3 deficiency: from molecules
to cortical processing
5.2.1 CRMP-5 and autophagosome dysregulation at the
origin of the dendritic phenotype?
To unite the molecular findings and the structural abnormalities in the cortex
of MMP-3-/- mice, a hypothetical molecular framework is summarized in figure
5.1. The framework can be divided in two alternative pathways based on
the yet unknown interpretation of the elevation in LC3-II levels: an increase
in autophagy (1) or a perturbed autophagosome clearance (2) (decreased
autophagy). As discussed in chapter 3 this can be resolved by determining the
autophagic flux [229]. For the time being, both possible outcomes can explain
certain aspects of the observed phenotype. The autophagy-dependent pathway
(1) has largely been described in chapter 3 and is based on the fact that CRMP-5
upregulation in primary cortical neurons inhibits dendrite outgrowth through
the upregulation of LC3-II and initiation of subsequent mitophagy [35]. In
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addition, CRMP-5 is known to inhibit microtubule polymerization [36] through
which it can a ect organelle transport and docking [201]. Together, this would
result in a decrease in the number of mitochondria in the apical dendrite and
spines which explains the observed reduction in apical dendritic length and
spine length of layer V pyramidal neurons in the visual cortex of MMP-3-/-
mice (figure 5.1).
Important to note is that the function of CRMPs is mainly determined by
their phosphorylation state, for example CRMP-2 can only bind to tubulin to
promote tubulin polymerization when it is dephosphorylated [372, 37], whereas
CRMP-5 needs to be phosphorylated to properly bind to tubulin to inhibit
polymerization [37]. In this way, phophorylation by enzymes such as GSK3—,
Cdk5 and Rho/ROCK-kinase can elegantly regulate the function of di erent
CRMPs in one location [37, 44, 372]. In this study we did not di erentiate
between the phosphorylation state of CRMPs and therefore it is possible that
the observed upregulation of CRMP-5 does not result in an elevated inhibition
of microtubule polymerization. In addition, Western analysis revealed no
di erences in the total level of the other CRMPs but a shift in phosphorylation
state can change their function. This line of reasoning also can also explain
why CRMP-2 and CRMP-3 are di erentially expressed in the 2-D DIGE study
and do not di er in expression levels when measured through Western analysis.
Finally, it is known that CRMPs form hetero-oligomers which alters their
function [352, 113, 273] and therefore an upregulation of CRMP-5 can impact
the function of other CRMPs. CRMP-5 preferentially forms oligmers with
CRMP-2, -3 and -4 and only weakly interacts with CRMP-1 [113].
Another explanation for the observed MMP-3-/- phenotype is a defective
autophagic flux caused by for example improper fusion between autophagosomes
and lysosomes or impaired lysosomal activity (figure 5.1, pathway 2) [229, 176].
Defective autophagosome clearance could explain the accumulation of NF
protein subunits since NF turnover is partially regulated by autophagy [129].
In addition, the observed upregulation of NF subunits could contribute to the
local decline in mitochondrial numbers because NF are necessary for proper
docking and distribution of mitochondria in dendrites [350, 118]. A reduction
in autophagosomal clearance of mitochondria can impact mitochondrial health
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by the inevitable increase of damaged mitochondria which in turn increases
oxidative stress [187]. Oxidative stress is inseparably linked to mitochondrial
dysfunction because mitochondria both generate and are targeted by reactive
oxygen species [241]. Indications of oxidative stress and reduced ATP levels
in MMP-3-/- mice were revealed in a proteomic screening of WT and MMP-
3-/- medial visual cortex (mitochondrial proteins involved are marked with an
asterisk in appendix table A.1). In turn, mitochondrial dysfunction can induce
autophagy in neurons. For example in NGF-deprived cultured neurons it has
been shown that mitochondrial ATP depletion causes an upregulation of LC3-II
and subsequent autophagy [384]. To conclude, both pathways described in
figure 5.1 can link the molecular data to the observed dendritic phenotype, with
mitochondrial dynamics as a potential central player. One important remark is
that we measured the levels of NF content with Western analysis of visual cortex
homogenates and thus the source of NF upregulation remains elusive and could
also come from changes in axon diameter, pyramidal neurons in other layers
and non-pyramidal neurons. This remark also holds true for the presumptions
made about CRMPs and autopaghic e ects since we do not have cell-specific
information about CRMP and LC3-II levels..
Future experiments to further dissect the proposed pathways in MMP-3-/- mice
include the determination of the autophagic flux to distinguish between pathway
1 and 2; co-localization studies of CRMP-5 with mitochondrial markers and
lysosomal markers to establish evidence for CRMP-5 mediated mitophagy;
assess the number, shape and dynamics of mitochondria with live cell imaging
in cultured primary cortical neurons; and analyze potential oxidative stress
using for example a combination of a commercial ROS assay, measurement of
antioxidant activity and DNA damage.
The upregulation and hyperphosphorylation of NF proteins and the presumptive
increase in autophagosmes observed in MMP-3-/- mice are reminiscent of
the molecular distortions observed in neurodegenerative disorders such as
Parkinson’s disease, Alzheimer’s disease and amyotrophic lateral sclerosis (ALS)
[195, 286, 196, 384]. Indeed, increased accumulation of autophagosomes has
been observed in Parkinson’s and Alzeimer’s disease, either due to a decrease
in autophagosome clearance or an overproduction of autophagosomes [288].
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Figure 5.1: Hypothetical molecular framework underlying the MMP-3 deficient
cortical phenotype.
The observed upregulation of CRMP-5 can lead to increased levels of LC3-II, which is
indicative for increased autophagy (1) or a reduction in autophagosome clearance (2).
The first pathway (1), in combination with the known function of CRMP-5 in inhibiting
microtubule polymerization, has e ect on the number of mitochondria present in the
dendrite which can explain the reduction in dendritic spine length and apical dendritic
length. The observed elevation in neurofilament protein levels hints towards an altered
stoichiometry which can influence the distribution and docking of mitochondria. The
second pathway (2) can account for the upregulation of neurofilament proteins since
the turnover is determined by autophagy. An impaired autophagosome clearance
accumulates dysfunctional mitochondria and produces oxidative stress, both of which
can impact the structural integrity of neurons. A reduced mitochondrial function
in turn stimulates autophagy onset which completes the cycle. Impairments in
CRMP-mediated Ca2+ signaling can additionally modulate various components in this
schematic (see text for details). Abbreviations: LC3-II, phosphatidylethanolamine-
conjugated microtubule-associated protein 1 light chain 3.
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In addition, abnormal phosphorylation of NF proteins which aggregate in
Lewy bodies and neuro-fibrillary tangles (NFT), are a hallmark of Parkinson’s
and Alzheimer’s disease respectively [196]. Alterations in NF proteins have
been postulated to be an early, preclinical event in the disease progression
of Alzheimer’s and specifically neurons containing NF proteins, such as
neocortical pyramidal cells are especially vulnerable to NFT formation [348, 78].
Interestingly, CRMPs are also involved in the pathophysiology of Alzheimer’s
disease [231]. Hyperphosphorylation of CRMP-2 inhibits neurite elongation
and impairs microtubule-related cargo transport which contributes to the
neurodegenerative process [274, 231]. A key protein in the pathophysiology
of Parkinsons disease, –-synuclein, interacts with the mitochondrial inner
membrane where it aggregates, causing mitochondrial dysfunction [187].
Moreover, –-synuclein is a known substrate of MMP-3 [40] which substantiates a
possible link between loss of MMP-3 and an aberrant mitochondrial function. In
mitochondrial-induced dopaminergic cell stress MMP-3 modulates the function
of DJ-1, a peroxidase that protects the neuron against oxidative, proteasomal
and mitochondrial stress [173]. Furthermore, –-synuclein promotes neurite
outgrowth by stimulating microtubule polymerization in cultured primary
cortical neurons [194]. However, MMP-3 is upregulated in both Parkinson’s and
Alzheimer’s disease and MMP-3 deficient mice display a reduced dopaminergic
cell death in a PD model [173, 357]. Still this provides a general link
between MMP functionality, oxidative stress, neurofilament dysregulation and
mitochondrial dynamics.
ALS is also characterized by an upregulation, hyperphosphorylation and
aggregation of NF subunits and a defective autophagsome clearance in motor
neurons [48, 67, 179]. Hyperphosphorylation of NF in ALS causes them to
detach from kinesin motors which results in a decrease in transport speed and
eventually leads to cytosolic accumulations [67, 371]. In our model however,
immunohistochemical analysis of NF-H did not reveal any NF aggregations
in the soma of layer V pyramidal neurons (supplementary figure A.2). In
accordance with our data, upregulation of NF-L prevents aggregation of other
overexpressed NF subunits [179]. In a specific mouse model of ALS, an increase
in LC3-labeled vacuoles were observed but it is not clear whether this is a result
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of an increased autophagic induction or impairment in autophagic flux [48].
The neurodegenerative diseases discussed here are all characterized by cell
death that is catalyzed by protein aggregation, oxidative stress and cytoskeletal
disruption. However, during disease progression it has been suggested that
reduction in mitochondrial activity is an early event that precedes cell death
[288]. Therefore it is conceivable that in MMP-3 deficient mice, a reduction
in mitochondrial function, for example by the actions of CRMP-5, causes the
observed neuronal architecture without apparent cell death.
Mitochondria serve as a Ca2+ bu er in dendritic spines and mitochondrial
dysfunction increases cytosolic Ca2+ [211, 201]. Constitutive high levels of
Ca2+, mainly imported through NMDA receptors and voltage-dependent Ca2+
channels (VDCC), reduce spine length [98]. Therefore, reduced mitochondrial
health by an impairment in autophagy or a lack of proper mitochondrial docking
to energy-demanding dendritic spines caused by alterations in neurofilament
composition, could cause a reduction in dendritic spine length in the visual
cortex of MMP-3-/- mice. These mice are characterized by an impaired VDCC-
dependent LTP in the hippocampus (personal communication with dr. G.
Wiera, lab of Prof. dr. J. W. Mozrzymas) and interestingly CRMPs are known
to bind to and modulate the transmission and distribution of VDCCs [358, 34].
Moreover, it has been established that a persistent or aberrant Ca2+ influx can
trigger autophagy [384]. Aberrant Ca2+ has also been linked to a decrease in
calpain acitivity, a protease responsible for NF degradation, which in turn results
in the increase of LC3-related proteins that are calpain substrates [370, 14].
Taken together, the observed upregulation of CRMP-5 can therefore modulate
CRMP-mediated VDCC Ca2+ influx to initiate changes in autophagosome
formation and neurofilament turnover. To conclude, an aberrant Ca2+ signaling
provides an attractive additional mechanism that can be superimposed on the
pathways displayed in figure 5.1.
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5.2.2 Truncated pyramidal neurons compromise cortical pro-
cessing
Pyramidal neurons can be considered as the main computational unit of the
neocortex, integrating information from various sources to give an appropriate
output [198, 125]. Therefore, a probable consequence of the reduced apical
dendritic length is that the information processing in V1 is disturbed.
Considering both the traditional model for cortical processing [324] and the
bistratified model of Constantinople and Bruno [57] (figure 1.2), the sensory
information coming from the dLGN can not be properly processed in this case.
Since structure and function are bidirectionally related you would expect severe
functional abnormalities. For example, on a cellular level the length of the apical
dendrite is inherently critical for proper dendritic computation because the
travel-time of a dendritic signal tends to attenuate accross the apical dendrite
up to the soma and therefore the length passively regulates the output signal
similar to an electrical cable with insulation [198].
Although we could not make the distinction between tall-tufted, tall-simple
and short pyramidal neurons [186, 185] due to the nature of the Golgi-Cox
stain, we observed a considerable reduction in apical dendritic length across all
examined neurons. A more detailed assessment of the di erent functionality
of the distinct pyramidal neuron populations could be made with single unit
electrophysiological recordings. A subset of pyramidal neurons (mostly tall-
tufted) are intrinsically bursting and typically project to subcortical areas such
as the superior colliculus and the pons to guide behavioral feedback [324, 125].
Therefore it would be interesting to assess the eye and head movements of
MMP-3-/- mice in an optomotor system to assess superior colliculus-dependent
behavior [281]. Other layer V pyramidal neurons are regular spiking and are
involved in cortico-cortical signaling [183]. These pyramidal neurons in V1
receive long-range feedback connections from and serve feedforward connections
to higher order visual areas [103, 186, 125]. An altered dendritic architecture
could therefore have a major impact on the integration of descending pathways
and top-down processing of visual information and influence the feedforward
processing in the dorsal and ventral stream [103, 8]. Conclusively, it is highly
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expected that the observed dendritic phenotype has a detrimental e ect on the
feedforward and feedback communication between V1 and extrastriate areas,
which in turn can impact the dorsal and ventral stream [8, 355]. In that regard
it would be very informative to functionally assess cortical processing using a
combination of voltage-sensitive dye optical imaging to map the information
flow between V1 and extrastriate areas and electrophysiological current source
density analyses [345] to map the interlaminar temporal processing in MMP-3-/-
mice.
Various behavioral experiments indicated that MMP-3-/- mice have impaired
motor skills which were correlated with developmental impairments in neuronal
migration and reduced Purkinje cell dendritogenesis in the cerebellum [339]. In
that regard, the dendritic phenotype of the visual cortex as described in this
manuscript and the concomitant abnormal visual information processing can
contribute to the impaired motor behavior. Indeed, direct functional connections
between V1 and motor cortex are present in rodents [289, 389, 226] and regular
spiking layer V pyramidal neurons project to the striatum, which is directly
involved in controlling motor behavior [324, 289].
The observed reduction in spine length on the apical shaft of the pyramidal
neurons can be correlated with synaptic strength. Spine length determines
the biochemical isolation of the spine and influences the electrical signaling
and generally, the shorter the neck of the spine, the less electrically isolated
it is from the parent dendrite [385, 386, 330]. In the case of MMP-3-/- mice,
shorter spines could therefore be characterized by a reduced biochemical and
electrical isolation which can influence dendritic computation [385, 330]. Spine
length is inversely correlated with synaptic strength but the latter is additionally
determined by spine head shape. The larger the head, the more current it can
inject into the dendrite. Therefore, in addition to spine length, spine head
shape is an important parameter in determining synaptic strength [385]. To
this end, spines are often categorized in di erent classes according to their
morphology: thin, stubby and mushroom spines [272, 31, 154]. Yet this discrete
categorization has been challenged and a morphological continuum of spines has
been proposed [385]. To better understand the e ect of MMP-3 deficiency on
circuit dynamics in the cortex, it would be useful to include parameters such as
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spine head width [292] or study spine morphology in detail in MMP-3-/- mice
using for example 3D electron microscopic reconstructions of individual spines
[31, 224, 385].
5.3 MMPs and ME-induced cortical plasticity: where
we are and where to go
Chapter 4 described the optimization of a fluorescent assay to measure the in
vivo activity of MMP-3. Several attempts to specifically immunoprecipitate
MMP-3 and detect the enzymatic activity failed since MMP-3-/- samples revealed
considerable enzymatic activity in the performed assay. To circumvent these
problems we opted for the use of Western analysis and combined this technique
with gelatin zymography to additionally assess the expression levels of MMP-2
and MMP-9. Only MMP-3 expression levels were significantly a ected by ME in
an age-dependent manner. No di erences in MMP-2 levels were found both in
the Western analysis and zymography. Surprisingly, MMP-9 was not detectable
using gelatin zymography in visual cortex samples.
The function and activity of MMPs in the visual cortex is still a largely unknown
territory. However, unraveling the precise function of these enzymes in the
visual cortex is of vital importance to comprehend cortical plasticity processes
and the role of the protease web herein. To this date, the techniques to study
the function of a specific MMP in a complex environment such as the brain are
still lacking specificity. Nevertheless, progress is being made in the development
of specific inhibitors [99, 267], the use of innovative techniques to accurately
measure MMP actvity [46, 133, 171, 342] and in gaining insight in the complex
degradome to identify novel MMP substrates and functions [82, 68, 295, 38].
5.3.1 Reliable assessment of MMP activity
In chapter 4 we measured MMP expression using Western analysis and we
could discern the active form of MMP-2 based on molecular weight. Although
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it provides us with an easy tool to demonstrate a potential link between
MMP expression levels and visual cortex plasticity, Western analysis of MMP
expression does not give accurate information concerning in vivo enzymatic
activity levels. For example, MMP-2 activity is also determined by the levels
of TIMP-2 present in the tissue and during the Western blot procedure the
MMP-2/TIMP-2 complex is partly dissociated. This is also the case when
using gel zymography to study MMP activity because also here the in vivo
MMP/TIMP complexes are dissociated during the electrophoresis procedure
[342]. Therefore it is important to note that the Western analysis and gel
zymography results presented in chapter 4 do not represent actual in vivo
active levels of MMP since we do not know how much MMP is bound to TIMP
in vivo. These analyses rather show the maximum level of potentially active
MMP and therefore this technique is valuable to uncover relative di erences
in experimental conditions. In addition, MMP activity can be underestimated
when measuring active MMPs based on molecular weight since proMMPs can be
activated by for example oxidative stress without complete proteolytic cleavage
of the prodomain [259, 346]. To substantiate the net MMP activity in samples a
combination of gel zymography and other complementary techniques, such as in
situ zymography and fluorescent activity assays similar to the one described in
Chapter 4 can be used. In situ zymography involves the sectioning of the tissue
and subsequent application of a quenched fluorescently-labeled substrate to
detect in vivo MMP activity [375]. This technique provides a 2D visualization
of in vivo MMP activity that can be combined with IHC and even allows for a
3D representation through serial section analysis [342, 375]. However, proper
controls such as selective MMP inhibitors or knockout samples have to be
incorporated to deduce the specificity of substrate proteolysis. Sectioning of
the tissue can also artificially mix MMPs and TIMPs which constrains the
interpretation of in vivo MMP activity [342]. In that regard, in vivo zymography
(IVZ) which relies on the infusion of a quenched fluorescently labeled substrate
in an intact organism, provides a valuable tool to study true in vivo MMP
activity [59, 171, 342]. To this date, IVZ has only been reported in transparent
species and small embryos [59, 171]. Recent development of near-infrared (NIR)
probes, characterized by low tissue absorption and reduced scattering coupled
to MMP specific hydroxamate inhibitors holds great promise for use in non-
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transparent, larger animals [172, 342], although this approach is still limited by
the specificity of current available MMP substrates and inhibitors.
Another method to study MMP activity in complex sample is to assess the
cleavage of endogenous MMP substrates. For example, the cleavage of the
synaptic plasma membrane protein —-dystroglycan has been used as a marker
for MMP-9 activity in the rodent hippocampus [222, 12]. However, caution
must be taken to ensure the substrate under study is spatiotemporally specific
for a certain MMP and approaches to unravel the in vivo protease web are
essential in this case [81, 68].
In this dissertation we provided preliminary data that highlights the importance
of MMP-3 over the gelatinases in potentially modulating plasticity in the visual
cortex. Therefore, a reliable measurement of in vivo MMP-3 activity in the
mouse visual cortex is essential to substantiate these results. One popular
way of detecting MMP-3 activity is casein zymography [147, 93, 275, 217].
However, casein is readily cleaved by serine proteases such as tissue plasminogen
activator and urokinase-type plasminogen activator with the latter having
a similar molecular weight as MMP-3 [238]. This makes interpretation of
MMP-3 zymolytic activity prone to error. In this case, 2D casein zymography
might be useful to separate proteases with similar molecular weights and
to ameliorate subsequent identification with mass spectrometry, ensuring the
accurate detection of MMP-3 [342]. As argumented above, zymography provides
useful but limited information as it does not reflect the in vivo activity of the
enzyme. Even the activity assay described in chapter 4 only measures the
net activity in a sample because of the mixture of MMPs and TIMPs during
tissue homogenization. However, the net activity in a sample would provide
more accurate information about the state of MMP activity in the organism
compared with the potential activity measured with zymography. Of note, a
similar activity assay has recently been successfully used to study the net activity
of MMP-9 in the rat brain [133]. Mass spectrometry-based approaches such as
the PSP-STEP method which incorporates standard MMP-derived peptides
to quantify the absolute enzymatic activity for a specific MMP in a sample
have been successfully performed but these techniques are also subject to the
dissociation of MMP/TIMP complexes [81]. The ultimate goal is to measure the
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true in vivo MMP activity in a spatiotemporal manner and in vivo zymography
provides a way to accomplish this. To measure the in vivo MMP-3 activity in
the visual cortex, a specific FRET or quenched NIR substrate can be injected
in the cortex and allow for real-time in vivo imaging of fluorescent signals
using multi-photon microscopy [137, 133]. Repeating this procedure at di erent
time-points post-ME could provide valuable data concerning ME-induced MMP
activity changes. However, this method would still be limited by the availability
of specific MMP-3 substrates and possibly their pharmacokinetics in brain
tissue. A combination of di erent approaches would yield the most accurate
information.
5.3.2 Towards a causal link between MMP function and ME-
induced cortical plasticity
In this dissertation we provided evidence for a modulation of proMMP-3 levels
in the visual cortex according to post-ME survival times in an age-dependent
manner. One logical experiment to establish a causal link between MMP activity
and ME-induced cortical plasticity would be to infuse a specific MMP inhibitor
intracortically in ME mice and evaluate the age-dependent reactivation in the
visual cortex. Several questions accompany such an experiment: 1) what is the
proper time window for inhibitor infusion? 2) can we link the observations to
a specific MMP with the chosen inhibitor? and 3) if the reactivation is not
modulated by infusion of an inhibitor, does this mean that MMPs do not have
a function in ME-induced cortical plasticity?
The first question can be answered with a similar approach as described in
chapter 4: assessment of the MMP activity in the visual cortex at di erent
post-ME survival times. However, reliable assessment of the in vivo MMP
activity is not very straightforward (see previous section). Purely on the basis
of the data described in chapter 4 we can prudently conclude that inhibition of
MMP-3 would be most relevant in P45 mice, specifically in the medial monocular
zone where MMP-3 levels are the highest. However, higher proMMP-3 levels
could reflect lower MMP-3 activity which would make this assumption incorrect.
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Therefore, a more accurate measurement of MMP-3 activity in the visual cortex
is necessary.
The second question deals with an established problem in the world of MMP
biology: the development of specific inhibitors and the use of MMPs as
therapeutic targets. Due to the large similarities of the catalytic cleft of di erent
MMPs, inhibitor design was not that straightforward as initially thought. Since
the discovery of MMPs in 1962, more than 70 pharmaceutical and biotech
companies strived to get MMP inhibitors (MMPI) on the market and extensive
phase III clinical trials were undertaken, without success [38, 390, 296]. Failure
of these MMPIs in clinical trials was attributed to poor selectivity with inhibition
of anti-targets, inadequate spatiotemporal dosing and poor knowledge of the
involved pathways and substrate repertoires [58, 267, 266]. An ideal inhibitor
for e ective therapeutics must be selective against a validated MMP target and
spare MMP anti-targets that would otherwise counterbalance the desired e ects
of inhibition [265]. In the past, hydroxamate-based MMPI were classically chosen
because of the strong binding of hydroxamate to the Zn2+ in the active site [265].
However, other non-MMP metalloenzymes were also inhibited by this type of
MMPIs and one example is the often used GM6001 broad spectrum MMPI [298].
Other Zn2+-binding moieties have been incorporated in MMPIs to increase
their specificity but highly specific inhibitors are still lacking [4, 284]. Classic
MMP inhibitor design relied heavily on static structure-activity relationship
analysis, which has proven to be very useful but does not take into account
that specific subsites of the catalytic domain are highly flexible [60, 235, 266].
Moreover, the conformational heterogeneity and flexibility of the catalytic
domain is the rule rather than an exception for MMPs [24]. Together this
dramatically limits the accurate modeling of MMP-inhibitor complexes in silico.
However, recent advances in the design of so-called "shape shifter" allosteric
inhibitors that perturb the substrate binding properties of the catalytic site
by binding to exosites holds great promise for increasing specificity of novel
MMPIs [304, 265]. This approach already led to the development of highly
selective MMP-13 inhibitors [248]. Using allosteric inhibitor design strategies,
an inhibitory peptide against MMP-9 was synthesized that specifically targets
the hemopexin domain without a ecting the proteolytic activity and as a
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result this peptide interferes with the integrin-binding capacity of the enzyme
[28, 304]. This type of approach paves the way for highly selective inhibition of
MMP activities in a biological context where only a very specific protein-protein
interaction needs to be targeted. The specificity of an inhibitor may be improved
by combining both interactions with the catalytic domain and exosites specific
to an individual MMP [304]. However, this approach only met with limited
success, likely because of the high independent mobility of di erent MMP
domains [158]. Another possible avenue for inhibitor design is to use functional
blocking antibodies due to their ability to selectively bind close-related antigens.
Selective functional blocking antibodies were discovered this way for MMP-9
and MMP-14 [208, 76]. In some cases more broad-spectrum inhibitors have
the advantage over specific ones for example when MMP redundancy is under
study or when a physiological process is regulated by the simultaneous activity
of several MMPs with low abundance anti-targets [266]. However, this still
requires prior knowledge of individual MMP function. To conclude, every e ort
made towards synthesis of novel inhibitors to increase specificity for a certain
MMP or set of MMPs is essential to progress the study of MMP function in
a complex biological environment and provide the opportunity to establish a
causal link between MMP function and manipulation.
Finally, the third question of the proposed experiment considers the fact that
the enzymatic activity of MMPs is not always the mechanism of operation by
which they regulate a physiological process. For example, MMP-9 can influence
signal transduction by binding to surface receptors with its hemopexin domain
[276, 287]. Therefore it is possible that infusion of a specific inhibitor that
blocks MMP acitvity would not modulate ME-induced cortical plasticity. In
that case it would be suitable to use an inhibitor specifically directed towards
the domain that serves the interaction, e.g. the hemopexin domain (see previous
paragraph).
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5.4 Concluding remarks
Knockout studies can provide valuable details about the mechanistics behind
the functioning of a protease web and future work on characterizing the MMP-
3-/- phenotype can contribute to this field. Nevertheless, to unambiguously
determine the activity and function of MMP-3 in the visual cortex, the techniques
available today are not straightforward enough and at least a combination of
di erent approaches should be used. All e orts to improve the synthesis of
specific inhibitors and improve the techniques available to study in vivo activity
of this enzyme would greatly advance the understanding of the complex MMP
biology and would eventually lead to successful therapeutic applications.
Post scriptum
Recently it was brought to our attention that the MMP-3-/- mice used in
this study harbor an inactivating mutation in the caspase-11 gene. A recent
publication by Kyagaki et al. (2011) revealed that the 129 mouse strain is
deficient for the caspase-11 gene located on chromosome 9 [167]. A follow-up
study in 2012 by Kenneth et al. revealed that when 129 cells are used to
target genes closely linked to caspase-11, the resulting mice might also carry the
caspase-11 deficiency as a passenger mutation, despite extensive backcrossing
to a C57Bl/6 background [170]. MMP-3 is located on chromosome 9 in close
proximity to caspase-11 and the MMP-3-/- mice used in this study are derived
from the 129 strain (The Jackson Laboratory). Indeed, genetic screening of
the MMP-3-/- mice revealed the inactivating mutation in the caspase-11 gene,
rendering these mice deficient for both genes. To exclude possible interference
of caspase-11 concerning the findings presented in this manuscript and to guide
future experiments, comparative studies using caspase-11-/- mice are needed.

Summary
The brain is able to change its functional and anatomical organization in response
to environmental changes and this ability is termed neuroplasticity. The visual
cortex, the area in the brain that receives visual input, is undoubtedly one of the
best and most studied areas of the brain for understanding cortical plasticity and
development. However, the molecular mechanisms governing cortical plasticity
are still elusive. Matrix metalloproteinases (MMPs) are Zn2+-dependent
endopeptidases considered to be essential for normal brain development and
neuroplasticity by modulating extracellular matrix proteins, receptors, adhesion
molecules, growth factors and cytoskeletal proteins. Specifically, MMP-3 has
recently been implicated in synaptic plasticity, hippocampus-dependent learning
and neuronal development and migration in the cerebellum. However, the
function of this enzyme in the neocortex is understudied. Therefore, we
explored the phenotypical characteristics of the neuronal architecture and
the capacity for experience-dependent cortical plasticity in the visual cortex
of adult MMP-3-deficient (MMP-3-/-) mice. Golgi–Cox stainings revealed a
significant reduction in apical dendritic length, spine length and an increased
number of apical obliques for layer V pyramidal neurons in the visual cortex of
adult MMP-3-/- mice compared to wildtype (WT) animals. To assess the e ect
of MMP-3 deficiency on cortical plasticity, we monocularly enucleated (ME)
adult MMP-3-/- mice and analyzed the reactivation of the contralateral visual
cortex seven weeks post-ME. In contrast to previous results in C57Bl/6J adult
mice, activity remained confined to the binocular zone and did not expand
into the monocular regions indicative for an aberrant open-eye potentiation.
Permanent hypoactivity in the monocular cortex lateral and medial to V1 also
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indicated a lack of cross-modal plasticity. These observations demonstrate
that genetic inactivation of MMP-3 has profound e ects on the structural
integrity and plasticity response of the visual cortex of adult mice. To further
assess the molecular changes governing the MMP-3-/- cortical phenotype, we
performed Western analysis on di erent neurofilament protein (NF) subunits
and collapsin response mediator proteins (CRMP). The former are markers for
a healthy cytoskeleton and determine the shape and architecture of neurons
whereas CRMPs are mainly involved in regulating neurite outgrowth through
microtubule polymerization. A significant upregulation of both phosphorylated
and non-phosphorylated NF-high, phosphorylated NF-medium, NF-low and
–-internexin was detected in the visual cortex of MMP-3-/- mice compared
with WT. These results suggest that an altered stoichiometry of NF subunits is
related to the truncated neuronal architecture observed in MMP-3-/- mice. In
addition, the expression level of CRMP-5 was significantly elevated in MMP-3-/-
samples whereas the levels of CRMP-1, -2, -3 and -4 did not di er compared with
WT mice. Recent literature indicates that overexpression of CRMP-5 negatively
regulates dendritic outgrowth by reducing the number of mitochondria through
increased autophagy and mitophagy. Therefore, we assesed the expression level
of a marker for autophagy, the microtubule-associated protein 1 light chain 3
(LC3-II) and found a significant increase in MMP-3-/- samples. The expression
levels of mitochondrial fusion protein mitofusin-2 (Mfn-2) and dynamin-related
protein 1 (Drp1), a mitochondrial fission protein, did not di er, indicating that
the mitochondrial fusion and fission balance is not altered in the visual cortex
of MMP-3-/- mice. Taken together, an altered NF composition, overexpression
of CRMP-5 and a possible upregulation of autophagy underlie the structural
phenotype in the visual cortex of MMP-3-/- mice.
To assess the acute role of MMPs in ME-induced visual cortex plasticity
we performed Western analysis for MMP-3 to reveal fluctuations in MMP-3
expression level associated with post-ME survival time in P45 and P120 mice.
This approach revealed significant di erences in proMMP-3 expression especially
in P45 mice both in the medial monocular and binocular zone whereas in P120
mice, enucleation did not induce large e ects on proMMP-3 expression. This
suggests that MMP-3 is potentially necessary to inhibit cross-modal plasticity
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as normally seen in P45 mice. However, no active form of MMP-3 was visible
using Western analysis and therefore we tried to optimize a fluorescent activity
assay to study MMP-3 proteolysis in visual cortex samples. However, when
performing this assay on samples of MMP-3-/- mice, a fluorescent signal in the
same range as P45 and P120 ME C57Bl/6J samples was measured, rendering this
technique unreliable. To extend the analysis of ME-induced cortical plasticity
to other MMPs, we focused on the gelatinases (MMP-2 and MMP-9) because
their function in synaptic plasticity is well established. Using a combination of
Western analysis and gelatin zymography we revealed no significant di erences in
MMP-2 expression in all conditions studied, suggesting that this enzyme does not
play a major role in ME-induced open-eye potentiation or cross-modal plasticity.
No suitable antibodies for MMP-9 were available and gelatin zymography did
not reveal detectable levels of MMP-9 proteolytic activity, possibly due to
sample preparation issues. To conclude, further research is needed to evaluate
the activity of di erent MMPs in the mouse visual cortex and this will provide
a basis for future experiments for pharmacological intervention to establish a
causal relationship between MMP function and ME-induced cortical plasticity.

Samenvatting
Onze hersenen zijn in staat om zichzelf functioneel en structureel aan te
passen aan omgevingsveranderingen en dit fenomeen wordt hersenplasticiteit
genoemd. De visuele cortex of het deel van de hersenen dat visuele informatie
ontvangt, is ongetwijfeld de meest bestudeerde hersenregio met betrekking
tot hersenplasticiteit en hersenontwikkeling. De moleculaire mechanismen
die hersenplasticiteit reguleren zijn echter nog steeds grotendeels ongekend.
Matrix metalloproteïnases (MMPs) zijn Zn2+-afhankelijke endopeptidases die
een essentïele functie hebben in normale hersenontwikkeling en neuroplasticiteit,
ondermeer door het moduleren van extracellulaire matrix proteïnen, receptoren,
adhesiemoleculen, groeifactoren en cytoskeletale proteïnen. Recent onderzoek
heeft aangetoond dat MMP-3 betrokken is bij synaptische plasticiteit,
hippocampaal-afhankelijk leren, en neuronale ontwikkeling en migratie in
het cerebellum. De functie van dit enzyme in de neocortex is echter weinig
onderzocht. Daarom hebben we een fenotypische karakterisatie ondernomen van
de neuronale architectuur en de capaciteit voor ervaringsafhankelijke corticale
plasticiteit in de visuele cortex van volwassen MMP-3-deficiënte (MMP-3-/-)
muizen. Golgi-Cox kleuringen toonden een significante reductie in de lengte
van apicale dendrieten, dendritische spines en een verhoogd aantal apicale
vertakkingen in laag V pyramidale neuronen in de visuele cortex van volwassen
MMP-3-/- muizen in vergelijking met wildtype (WT) dieren. Om het e ect van
MMP-3 deficïentie op corticale plasticiteit na te gaan werden volwassen MMP-3-/-
muizen monoculair geënucleëerd (ME) en de reactivatie van de contralaterale
visuele cortex werd geanalyseerd zeven weken na ME. In tegenstelling tot
resultaten in volwassen C57Bl/6J muizen bleef de neurale activiteit beperkt
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tot de binoculaire zone en breidde niet uit tot de monoculaire zones, wat een
verstoorde open-oog potentiatie doet vermoeden. Permanente hypoactiviteit
in de monoculaire cortex lateraal en mediaal van V1 suggereerde eveneens een
gebrek aan crossmodale plasticiteit. Deze observaties tonen aan dat genetische
inactivatie van MMP-3 grote gevolgen heeft voor de structurele integriteit
en de plasticiteitsrespons van de visuele cortex in volwassen muizen. Om de
moleculaire veranderingen achter dit MMP-3-/- fenotype verder te achterhalen
werd een Western analyse uitgevoerd op verschillende neurofilament proteïne
(NF) subeenheden alsook op collapsine respons mediator proteïnes (CRMP).
NF zijn merkers voor een gezond cytoskelet en bepalen de vorm en architectuur
van neuronen terwijl CRMPs vooral betrokken zijn bij neuriet uitgroei door het
moduleren van microtubule polymerisatie. Een significante stijging van zowel
de gefosforyleerde en niet-gefosforyleerde vorm van NF-high, gefosforyleerd
NF-medium, NF-low en –-internexine werd geobserveerd in de visuele cortex
van MMP-3-/- muizen in vergelijking met WT. Deze resultaten suggereren dat
een verandering in stoichiometrie van NF subeenheden gerelateerd is aan de
afwijkende neuronale architectuur dewelke MMP-3-/- muizen karakteriseert.
Daarbovenop werd een significant verhoogde CRMP-5 expressie vastgesteld in
MMP-3-/- stalen in tegenstelling tot de onveranderde expressie van CRMP-1,
-2, -3 en -4. Recente publicaties tonen aan dat een overexpressie van CRMP-5
de uitgroei van dendrieten negatief reguleert door het aantal mitochondriën
in een neuron te verminderen door processen zoals autofagie en mitofagie.
Om een mogelijke bijdrage van deze processen in kaart te brengen werd
de expressie van de autofagiemerker microtubule-associated protein 1 light
chain 3 (LC3-II) nagegaan en we vonden een significante overexpressie van dit
molecule in MMP-3-/- muizen. De expressie van het mitochondriaal fusieproteïne
mitofusin-2 (Mfn-2) en dynamin-related proteïne 1 (Drp1), verantwoordelijk voor
mitochondriale fissie, vertoonde geen verschillen in expressie en dit suggereert
dat de mitochondriale fusie en fissie balans ongewijzigd is in de visuele cortex
van MMP-3-/- muizen. Algemeen kunnen we besluiten dat een veranderde NF
compositie, overexpressie van CRMP-5 en een mogelijke verhoging in autofagie
aan de basis ligt van het structurele fenotype in de visuele cortex van MMP-3-/-
muizen.
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Om de acute rol van MMPs in ME-geïnduceerde visuele cortex plasitciteit na te
gaan werd een Western analyse uitgevoerd voor MMP-3 om de fluctuaties
in MMP-3 expressie na te gaan die geassocieerd zijn met verschillende
overlevingstijden na ME in P45 en P120 oude muizen. Dit experiment toonde
significante verschillen aan in proMMP-3 expressie in P45 muizen zowel in
de mediaal monoculaire als de binoculaire zone terwijl bij P120 muizen de
proMMP-3 expressie na enucleatie niet significant wijzigde. Dit suggereert
dat MMP-3 potentiëel noodzakelijk is om, zoals het geval is in P45 muizen,
crossmodale plasticiteit te verhinderen. Desalniettemin werd geen actieve
vorm van MMP-3 gedetecteerd via Western analyse en daarom probeerden
we een fluorescente activiteitsassay te optimaliseren om de proteolytische
activiteit van MMP-3 op te meten in de visuele cortex. Echter, wanneer
uitgevoerd op MMP-3-/- stalen, toonde deze assay een fluorescent signaal met
gelijkaardige sterkte als in P45 en P120 C57Bl/6J stalen waardoor deze techniek
onbetrouwbaar werd verklaard. Om de analyse van ME-geïnduceerde corticale
plasticiteit uit te breiden naar andere MMPs werd vervolgens aandacht besteed
aan de gelatinases (MMP-2 en MMP-9) aangezien hun functie in synaptische
plasticiteit welgekend is. Gebruikmakend van een combinatie van Western
analyse en gelatine zymografie werden geen significante verschillen in MMP-2
expressie gevonden in alle geteste condities. Voor MMP-9 was geen geschikt
antilichaam beschikbaar en gelatine zymografie toonde geen detecteerbare
proteolytische activiteit van MMP-9 wat mogelijks te verklaren valt door
problemen met staalvoorbereiding. Algemeen kunnen we besluiten dat meer
onderzoek nodig is omtrent de evaluatie van MMP activiteit in de visuele cortex
van de muis. Een duidelijke meting van specifieke MMP activiteit zal de basis
leggen voor nieuwe farmacologische experimenten met oog op het aantonen
van een causaal verband tussen MMP functie en ME-geïnduceerde corticale
plasticiteit.
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Figure A.1: Total number of di erential spots between the visual cortex of WT and
MMP-3-/- mice.
A 2-D DIGE study was performed on the medial monocular cortex of WT
(n=4/condition) and MMP-3-/- (n=4/condition). Procedures dealing with 2-D DIGE
experiments have been described in detail elsewhere [335, 55, 146]. In brief, 50 µg
protein of each visual cortex sample was randomly labeled with either propyl-Cy3 or
methyl-Cy5. Equal fractions of all samples were pooled and 50 µg of this pool was
labeled with Cy2 to serve as an internal standard. Gels were scanned with the Ettan
DIGE Imager (software 1.0; GE Healthcare) and generated gel image triplets (Cy2,
Cy3, and Cy5). Spot detection and matching was performed automatically with the
DeCyder Batch processor and checked manually. Statistical analysis between the two
conditions was accomplished by the independent Student’s t-test. Here, a total of 16
di erential spots with P < 0.01 and 0.01 > P < 0.05 with a ratio of 1.30 or higher are
highlighted on a Cy2 image (pool sample). Each spot is delineated in green and is
assigned a number for subsequent MS/MS identification.
APPENDIX 125
Sp
ot
 #
Id
en
tif
ic
at
io
n
Av
er
ag
e 
R
at
io
 (-
/- 
/ W
T)
p-
va
lu
e
M
as
co
t s
co
re
# 
pe
pt
id
e 
m
at
ch
es
12
2
*A
co
ni
ta
te
 h
yd
ra
ta
se
, m
ito
ch
on
dr
ia
l p
re
cu
rs
or
1,
34
0,
00
46
40
6
25
13
7
*D
yn
am
in
 1
-li
ke
 p
ro
te
in
-1
,3
6
0,
03
70
19
3
19
19
1
S
er
um
 a
lb
um
in
 p
re
cu
rs
or
1,
52
0,
01
80
72
7
36
27
7
T-
co
m
pl
ex
 p
ro
te
in
 1
 (T
C
P
1)
 s
ub
un
it 
ze
ta
-2
,0
8
0,
00
24
28
8
23
C
ol
la
ps
in
 re
sp
on
se
 m
ed
ia
to
r p
ro
te
in
 3
 (C
R
M
P
-3
)
28
5
24
34
4
C
ol
la
ps
in
 re
sp
on
se
 m
ed
ia
to
r p
ro
te
in
 2
 (C
R
M
P
-2
)
-1
,3
1
0,
04
91
47
1
30
G
lu
co
se
-6
-p
ho
sp
ha
te
 d
eh
yd
ro
ge
na
se
 (G
6P
D
H
)
24
6
27
34
6
T-
co
m
pl
ex
 p
ro
te
in
 1
 (T
C
P
1)
 s
ub
un
it 
de
lta
-1
,4
1
0,
01
42
14
4
16
*A
TP
 s
yn
th
as
e,
 m
ito
ch
on
dr
ia
l F
1 
co
m
pl
ex
, a
lp
ha
 s
ub
un
it
14
3
15
38
7
*A
TP
 s
yn
th
as
e,
 m
ito
ch
on
dr
ia
l F
1 
co
m
pl
ex
, a
lp
ha
 s
ub
un
it
1,
56
0,
02
65
25
2
16
Tu
bu
lin
 T
 b
et
a1
5
17
6
21
60
1
R
ib
os
om
al
 p
ro
te
in
 S
A
-1
,3
3
0,
04
44
49
1
23
65
6
N
eu
ro
na
l-s
pe
ci
fic
 s
ep
tin
-3
-1
,1
8
0,
00
16
10
1
17
67
2
H
et
er
og
en
eo
us
 n
uc
le
ar
 ri
bo
nu
cl
eo
pr
ot
ei
n 
A
3 
(H
nr
pa
3)
, p
ar
tia
l
-1
,3
2
0,
00
64
24
1
13
G
ly
ce
ra
ld
eh
yd
e-
3-
ph
os
ph
at
e 
de
hy
dr
og
en
as
e 
(G
A
P
D
H
)
14
1
16
68
4
no
 id
en
tif
ic
at
io
n
-2
,6
6
0,
03
22
93
9
A
ct
in
-r
el
at
ed
 p
ro
te
in
 2
/3
 c
om
pl
ex
 (A
rp
 2
/3
) s
ub
un
it 
3
1,
41
0,
03
52
36
2
24
96
3
no
 id
en
tif
ic
at
io
n
-1
,3
2
0,
01
61
96
7
*N
A
D
H
 d
eh
yd
ro
ge
na
se
, s
ub
un
it 
C
2
1,
37
0,
03
76
11
6
8
10
27
no
 id
en
tif
ic
at
io
n
1,
44
0,
01
38
10
28
T-
co
m
pl
ex
 p
ro
te
in
 1
 (T
C
P
1)
 s
ub
un
it 
ze
ta
3,
54
0,
00
01
15
6
22
Table A.1: List of all di erential spots with identified proteins for WT versus MMP-
3-/- samples.
This table shows the spot number, identified proteins, the ratios, p-values, the Mascot
probability score and the number of matched peptides for each di erential spot. If the
ratio has a positive value this indicates a higher expression in the MMP-3-/- samples
compared to WT and vice versa. Identifications were obtained by MALDI-TOF/TOF
at Centre de Recherche Public, Grabriel Lippmann, Luxembourg. In several spots
more than one protein was identified and some analyzed spots did not result in a
reliable identification. Protein identifications related to mitochondrial function and
dynamics are highlighted with an asterisk.
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Figure A.2: Immunohistochemical detection of NF-H in pyramidal neurons in the
visual cortex of WT and MMP-3-/- mice.
Non-phosphorylated NF-H, detected with primary antibody SMI32R (1:1000, Covance),
shows no indications of neurofilament aggregation in the soma of pyramidal neurons
in the visual cortex of MMP-3-/- mice compared with WT. Stainings were performed
on 10 µm sections of paraformaldehyde-fixed tissue (secondary antibody: Alexa Fluor
488, 1:250). Scale bars: 10 µm. Abbreviations: DAPI, 4’,6-diamidino-2-phenylindole
(nuclear staining).
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Table A.2: Di erent names used for CRMPs in distinct species and by di erent
laboratory groups.
Abbreviations: TOAD-64, Turned On After Division 64 kDa; Unc, Uncoordinated.
Adapted from [54].
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